0000950170-22-018732 | 10-K | XBRL Viewer

Print Document View Excel Document

Cover Page - USD ($) $ in Billions	12 Months Ended
Cover Page - USD ($) $ in Billions	Jul. 31, 2022	Aug. 31, 2022	Jan. 31, 2022
Entity Information [Line Items]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Jul. 31, 2022
Document Transition Report	false
Entity File Number	001-37883
Entity Registrant Name	NUTANIX, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	27-0989767
Entity Address, Address Line One	1740 Technology Drive, Suite 150
Entity Address, City or Town	San Jose
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95110
City Area Code	408
Local Phone Number	216-8360
Title of 12(b) Security	Class A Common Stock, $0.000025 par value per share
Trading Symbol	NTNX
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 6.0
Entity Common Stock, Shares Outstanding (in shares)		227,032,085
Documents Incorporated by Reference	DOCUMENTS INCORPORATED BY REFERENCE As noted herein, certain information called for by Parts II and III is incorporated by reference to specified portions of the registrant’s definitive proxy statement to be filed in conjunction with the registrant’s 2022 annual meeting of stockholders, which is expected to be filed not later than 120 days after the registrant's fiscal year ended July 31, 2022.
Entity Central Index Key	0001618732
Current Fiscal Year End Date	--07-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Amendment Flag	false
Auditor Firm ID	34
Auditor Name	DELOITTE & TOUCHE LLP
Auditor Location	San Jose, California

CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands

Jul. 31, 2022

Jul. 31, 2021

Current assets:

Cash and cash equivalents

$ 402,850

$ 285,723

Short-term investments

921,429

928,006

Accounts receivable, net of allowances of $892 and $644, respectively

124,559

180,781

Deferred commissions—current

115,356

110,935

Prepaid expenses and other current assets

93,787

56,816

Total current assets

1,657,981

1,562,261

Property and equipment, net

113,440

131,621

Operating lease right-of-use assets

118,740

105,903

Deferred commissions—non-current

252,234

232,485

Intangible assets—net

15,829

32,012

Goodwill

185,260

Other assets—non-current

22,265

27,954

Total assets

2,365,749

2,277,496

Current liabilities:

Accounts payable

44,931

47,056

Accrued compensation and benefits

149,811

162,337

Accrued expenses and other current liabilities

49,232

39,404

Deferred revenue—current

720,993

636,421

Operating lease liabilities—current

39,801

42,670

Convertible senior notes, net current

145,456

Total current liabilities

1,150,224

927,888

Deferred revenue—non-current

724,545

676,502

Operating lease liabilities—non-current

89,782

86,599

Convertible senior notes, net

1,156,205

1,055,694

Derivative Liability

500,175

Other liabilities-non-current

35,161

42,679

Total liabilities

3,155,917

3,289,537

Commitments and contingencies (Note 7)

Stockholders’ (deficit) equity:

Preferred stock, par value of $0.000025 per share-200,000 shares authorized as of July 31, 2021 and 2022; no shares issued and outstanding as of July 31, 2021 and 2022

Common stock, par value of $0.000025 per share-1,200,000 (1,000,000 Class A, 200,000 Class B) and 1,042,004 (1,000,000 Class A, 42,004 Class B) shares authorized as of July 31, 2021 and 2022, respectively; 214,210 (208,579 Class A and 5,631 Class B) and 226,938 (226,938 Class A and zero Class B) shares issued and outstanding as of July 31, 2021 and 2022, respectively (1)

^[1]

Additional paid-in capital

3,583,928

2,615,317

Accumulated other comprehensive income (loss)

(6,076)

(8)

Accumulated deficit

(4,368,026)

(3,627,355)

Total stockholders' deficit

(790,168)

(1,012,041)

Total liabilities and stockholders' deficit

$ 2,365,749

$ 2,277,496

[1]	Effective January 3, 2022, all of the then outstanding shares of Nutanix, Inc. Class B common stock were automatically converted into the same number of shares of Nutanix, Inc. Class A common stock. See Note 8 for further details.

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Jul. 31, 2022	Jul. 31, 2021
Accounts receivable, allowance	$ 644	$ 892
Preferred stock, par value (in dollars per share)	$ 0.000025	$ 0.000025
Preferred stock, shares authorized (in shares)	200,000,000	200,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, shares authorized (in shares)	1,042,004,000	1,200,000,000
Common stock, shares issued (in shares)	226,938,000	214,210,000
Common stock, shares outstanding (in shares)	226,938,000	214,210,000
Common Class A
Common stock, par value (in dollars per share)	$ 0.000025	$ 0.000025
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	226,938,000	208,579,000
Common stock, shares outstanding (in shares)	226,938,000	208,579,000
Common Class B
Common stock, par value (in dollars per share)	$ 0.000025	$ 0.000025
Common stock, shares authorized (in shares)	42,004,000	200,000,000
Common stock, shares issued (in shares)	0	5,631,000
Common stock, shares outstanding (in shares)	0	5,631,000

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands

12 Months Ended

Jul. 31, 2022

Jul. 31, 2021

Jul. 31, 2020

Revenue:

Total revenue

$ 1,580,796

$ 1,394,364

$ 1,307,682

Cost of revenue:

Total cost of revenue

321,156

291,906

286,689

Gross profit

1,259,640

1,102,458

1,020,993

Operating expenses:

Sales and marketing

978,704

1,052,508

1,160,389

Research and development

571,962

556,950

553,978

General and administrative

166,418

153,782

135,547

Total operating expenses

1,717,084

1,763,240

1,849,914

Loss from operations

(457,444)

(660,782)

(828,921)

Other expense, net

(320,830)

(354,991)

(26,300)

Loss before provision for income taxes

(778,274)

(1,015,773)

(855,221)

Provision for income taxes

19,264

18,487

17,662

Net loss

$ (797,538)

$ (1,034,260)

$ (872,883)

Net loss per share attributable to Class A and Class B common stockholders-basic

^[1]

$ (3.62)

$ (5.01)

$ (4.48)

Net loss per share attributable to Class A and Class B common stockholders-diluted

^[1]

$ (3.62)

$ (5.01)

$ (4.48)

Weighted average shares used in computing net loss per share attributable to Class A and Class B common stockholders-basic

^[1]

220,529

206,475

194,719

Weighted average shares used in computing net loss per share attributable to Class A and Class B common stockholders-diluted

^[1]

220,529

206,475

194,719

Product

Revenue:

Total revenue

$ 757,623

$ 705,804

$ 765,822

Cost of revenue:

Total cost of revenue

55,602

55,287

71,312

Support, Entitlements and Other Services

Revenue:

Total revenue

823,173

688,560

541,860

Cost of revenue:

Total cost of revenue

$ 265,554

$ 236,619

$ 215,377

[1]	Effective January 3, 2022, all of the then outstanding shares of Nutanix, Inc. Class B common stock were automatically converted into the same number of shares of Nutanix, Inc. Class A common stock. See Note 8 for further details.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2020
Statement of Comprehensive Income [Abstract]
Net loss	$ (797,538)	$ (1,034,260)	$ (872,883)
Other comprehensive loss, net of tax:
Change in unrealized loss on available-for-sale securities, net of tax	(6,068)	(2,038)	1,361
Comprehensive loss	$ (803,606)	$ (1,036,298)	$ (871,522)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

+ Details

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Stockholders' (deficit) equity, beginning balance at Jul. 31, 2019	$ 186,893	$ 5	$ 1,835,528	$ 669	$ (1,649,309)
Stockholders' equity, beginning balance (in shares) at Jul. 31, 2019		188,595,000
Increase (Decrease) in Stockholders' Deficit
Issuance of common stock through employee equity incentive plans	7,024		7,024
Issuance of common stock through employee equity incentive plans (in shares)		10,034,000
Issuance of common stock from ESPP purchase	50,630		50,630
Issuance of common stock from ESPP purchase (in shares)		3,320,000
Stock-based compensation	351,998		351,998
Other comprehensive income (loss)	1,361			1,361
Net loss	(872,883)				(872,883)
Stockholders' (deficit) equity, ending balance at Jul. 31, 2020	(274,977)	$ 5	2,245,180	2,030	(2,522,192)
Stockholders' equity, ending balance (in shares) at Jul. 31, 2020		201,949,000
Increase (Decrease) in Stockholders' Deficit
Issuance of common stock through employee equity incentive plans	15,601		15,601
Issuance of common stock through employee equity incentive plans (in shares)		13,457,000
Issuance of common stock from ESPP purchase	50,167		50,167
Issuance of common stock from ESPP purchase (in shares)		3,980,000
Repurchase and retirement of common stock	(125,079)		(54,176)		(70,903)
Repurchase and retirement of common stock (in shares)		(5,176,000)
Stock-based compensation	358,545		358,545
Other comprehensive income (loss)	(2,038)			(2,038)
Net loss	(1,034,260)				(1,034,260)
Stockholders' (deficit) equity, ending balance at Jul. 31, 2021	(1,012,041)	$ 5	2,615,317	(8)	(3,627,355)
Stockholders' (deficit) equity, ending balance (ASU 2020-06) at Jul. 31, 2021	$ (48,013)		(148,598)		100,585
Stockholders' equity, ending balance (in shares) at Jul. 31, 2021	214,210,000	214,210,000
Increase (Decrease) in Stockholders' Deficit
2026 Notes derivative liability reclassification	$ 698,213		698,213
Issuance of common stock through employee equity incentive plans	6,480	$ 1	6,479
Issuance of common stock through employee equity incentive plans (in shares)		11,270,000
Issuance of common stock from ESPP purchase	62,633		62,633
Issuance of common stock from ESPP purchase (in shares)		2,827,000
Repurchase and retirement of common stock	(58,570)		(14,852)		(43,718)
Repurchase and retirement of common stock (in shares)		(1,369,000)
Unwinding of 2023 Notes hedges	39,880		39,880
Unwinding of 2023 Notes warrants	(18,390)		(18,390)
Stock-based compensation	343,246		343,246
Other comprehensive income (loss)	(6,068)			(6,068)
Net loss	(797,538)				(797,538)
Stockholders' (deficit) equity, ending balance at Jul. 31, 2022	$ (790,168)	$ 6	$ 3,583,928	$ (6,076)	$ (4,368,026)
Stockholders' equity, ending balance (in shares) at Jul. 31, 2022	226,938,000	226,938,000

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands

12 Months Ended

Jul. 31, 2022

Jul. 31, 2021

Jul. 31, 2020

Cash flows from operating activities:

Net loss

$ (797,538)

$ (1,034,260)

$ (872,883)

Adjustments to reconcile net loss to net cash (used in) provided by operating activities

Depreciation and amortization

87,952

94,373

93,773

Stock-based compensation

343,246

358,545

351,998

Change in fair value of derivative liability

198,038

269,265

Loss on debt extinguishment

64,910

Amortization of debt discount and issuance cost

40,233

63,859

31,313

Operating lease cost, net of accretion

36,905

34,757

30,374

Impairment and early exit of lease-related assets

597

1,420

3,002

Non-cash interest expense

19,270

16,074

Other

9,282

6,380

324

Changes in operating assets and liabilities:

Accounts receivable, net

60,998

64,483

4,334

Deferred commissions

(24,170)

(127,891)

(61,816)

Prepaid expenses and other assets

(36,166)

4,057

10,089

Accounts payable

(1,461)

(5,762)

(16,574)

Accrued compensation and benefits

(19,674)

50,916

18,765

Accrued expenses and other liabilities

4,049

14,824

3,400

Operating leases, net

(46,773)

(37,582)

(28,394)

Deferred revenue

127,845

126,732

272,410

Net cash (used in) provided by operating activities

67,543

(99,810)

(159,885)

Cash flows from investing activities:

Maturities of investments

1,058,116

784,176

645,828

Purchases of investments

(1,081,246)

(1,392,737)

(607,194)

Sales of investments

17,999

70,055

75,413

Purchases of property and equipment

(49,058)

(58,647)

(89,488)

Net cash provided by (used in) investing activities

(54,189)

(597,153)

24,559

Cash flows from financing activities:

Payments of debt extinguishment costs

(14,709)

Proceeds from unwinding of convertible note hedges

39,880

Payments for unwinding of warrants

(18,390)

Proceeds from sales of shares through employee equity incentive plans

67,826

65,766

57,797

Proceeds from the issuance of convertible notes, net of issuance costs

88,687

723,617

Repurchases of common stock

(58,570)

(125,079)

Payment of finance lease obligations

(1,089)

(459)

Net cash provided by financing activities

103,635

663,845

57,797

Net (decrease) increase in cash, cash equivalents and restricted cash

116,989

(33,118)

(77,529)

Cash, cash equivalents and restricted cash—beginning of period

288,873

321,991

399,520

Cash, cash equivalents and restricted cash—end of period

405,862

288,873

321,991

Restricted cash

^[1]

3,012

3,150

3,254

Cash and cash equivalents—end of period

402,850

285,723

318,737

Supplemental disclosures of cash flow information:

Cash paid for income taxes

20,353

16,639

16,625

Supplemental disclosures of non-cash investing and financing information:

Purchases of property and equipment included in accounts payable and accrued liabilities

17,139

12,832

$ 4,630

Finance lease liabilities arising from obtaining right-of-use assets

$ 10,491

$ 8,299

[1]	Included within other assets—non-current in the consolidated balance sheets.

Overview and Summary of Significant Accounting Policies

12 Months Ended

Jul. 31, 2022

Accounting Policies [Abstract]

Overview and Summary of Significant Accounting Policies

NOTE 1. OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Organization and Description of Business

Nutanix, Inc. was incorporated in the state of Delaware in September 2009. Nutanix, Inc. is headquartered in San Jose, California, and together with its wholly-owned subsidiaries (collectively, "we," "us," "our" or "Nutanix"), has operations throughout North America, Europe, Asia Pacific, the Middle East, Latin America and Africa.

We provide a leading enterprise cloud platform, which we call the Nutanix Cloud Platform, that consists of software solutions and cloud services that power our customers’ enterprise infrastructure. Our solutions deliver a consistent cloud operating model across edge, private-, hybrid- and multicloud environments for all applications and their data. Our solutions allow organizations to simply move their workloads, including enterprise applications, high-performance databases, end-user computing and virtual desktop infrastructure ("VDI") services, container-based modern applications, and analytics applications, between on-premises and public clouds. Our solutions are primarily sold through channel partners and original equipment manufacturers ("OEMs") (collectively, "Partners"), and delivered directly to our end customers.

Principles of Consolidation

The accompanying consolidated financial statements, which include the accounts of Nutanix, Inc. and its wholly-owned subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States ("U.S. GAAP"). All intercompany accounts and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. Such management estimates and assumptions include, but are not limited to, the best estimate of selling prices for products and related support; useful lives and recoverability of intangible assets and property and equipment; allowance for credit losses; determination of fair value of stock-based awards; accounting for income taxes, including the valuation allowance on deferred tax assets and uncertain tax positions; warranty liability; purchase commitment liabilities to our contract manufacturers; sales commissions expense and the period of benefit for deferred commissions; whether an arrangement is or contains a lease; the incremental borrowing rate to measure the present value of right-of-use assets and lease liabilities; the inputs used to determine the fair value of the contingent liability associated with the conversion feature of the 2.50% convertible senior notes due 2026 (the "2026 Notes"); and contingencies and litigation. Management evaluates these estimates and assumptions on an ongoing basis using historical experience and other factors and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions.

In response to the ongoing and continuously evolving COVID-19 pandemic, we considered the impact of the economic implications on our critical and significant accounting estimates, including assessment of collectibility of customer contracts, valuation of accounts receivable, provision for purchase commitments to our contract manufacturers and impairment of long-lived assets, right-of-use assets, and deferred commissions.

Concentration of Risk

Credit Risk — Financial instruments that potentially subject us to concentrations of credit risk consist of cash and cash equivalents and accounts receivable. We invest only in high-quality credit instruments and maintain our cash and cash equivalents and available-for-sale investments in fixed income securities. Management believes that the financial institutions that hold our investments are financially sound and, accordingly, are subject to minimal credit risk. Our deposits are with multiple institutions, however such deposits may exceed federally insured limits. We provide credit, in the normal course of business, to a number of companies and perform credit evaluations of our customers.

Concentration of Revenue and Accounts Receivable — We sell our products primarily through our Partners and occasionally directly to end customers. For the fiscal years ended July 31, 2020, 2021 and 2022, no end customer accounted for more than 10% of total revenue or accounts receivable.

For each significant Partner, revenue as a percentage of total revenue and accounts receivable as a percentage of total accounts receivable, net are as follows:


	Revenue									Accounts Receivable as of
	Fiscal Year Ended July 31,									July 31, 2021			July 31, 2022
Partners	2020			2021			2022
Partner A		29	%		32	%		33	%		35	%		26	%
Partner B		14	%		15	%		15	%		23	%		11	%
Partner C	(1)				10	%		11	%	(1)			(1)

(1)

Less than 10%

Summary of Significant Accounting Policies

Cash, Cash Equivalents and Short-Term Investments

We classify all highly liquid investments with original maturities of three months or less from the date of purchase as cash equivalents and all highly liquid investments with stated maturities of greater than three months as marketable securities.

We determine the appropriate classification of our marketable securities at the time of purchase and reevaluate such designation as of each balance sheet date. We classify and account for our marketable securities as available-for-sale securities. We classify our marketable securities with stated maturities greater than twelve months as short-term investments due to our intent and ability to use these securities to support our current operations.

Our marketable securities are recorded at their estimated fair value. Unrealized gains or losses on available-for-sale securities are reported in other comprehensive income (loss). We periodically review whether our securities may be other-than-temporarily impaired, including whether or not (i) we have the intent to sell the security or (ii) it is more likely than not that we will be required to sell the security before its anticipated recovery. If one of these factors is met, we will record an impairment loss associated with our impaired investment. The impairment loss will be recorded as a write-down of investments in our consolidated balance sheets and a realized loss within other expense in our consolidated statements of operations.

Fair Value Measurement

We define fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, we consider the principal or most advantageous market in which to transact and the market-based risk. We apply fair value accounting for all assets and liabilities that are recognized or disclosed at fair value in our consolidated financial statements on a recurring basis. The carrying amounts reported in our consolidated financial statements for cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate their fair values due to their short-term nature. The fair value of the 0% convertible senior notes due 2023 (the "2023 Notes") is determined based on the closing trading price per $100 of the 2023 Notes as of the last day of trading for the period. The fair value of the 2.50% convertible senior notes due 2026 is determined based on a binomial model. The fair value of the 0.25% convertible senior notes due 2027 (the "2027 Notes") is determined based on the closing trading price per $100 of the 2027 Notes as of the last day of trading for the period.

Convertible Senior Notes

Our convertible senior notes, including any embedded conversion features, are accounted for under the traditional convertible debt accounting model and are treated as a liability, net of unamortized issuance costs. The carrying amount of the liability is classified as a current liability if we have committed to settle with current assets; otherwise, it is classified as a long-term liability, as we retain the option to settle conversion requests in shares of our Class A common stock. The embedded conversion features are not remeasured as long as they do not meet the separation requirement of a derivative; otherwise, they are classified as derivative instruments and accounted for as such. Issuance costs are amortized to interest expense using the effective interest rate method over the term of the notes. In accounting for conversions of the notes, the carrying amount of the converted notes is reduced by the total consideration paid or issued for the respective converted notes and the difference is recorded to additional paid-in capital on our consolidated balance sheets. In accounting for extinguishments of the notes, the reacquisition price of the extinguished notes is compared to the carrying amount of the respective extinguished notes and a gain or loss is recorded in other expense, net on our consolidated statements of operations.

Derivative Liability

We evaluate convertible notes or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for under the relevant sections of Accounting Standards Codification ("ASC") 815-40, Derivatives and Hedging: Contracts in Entity’s Own Equity. The result of this accounting guidance could result in the fair value of a financial instrument being classified as a derivative instrument and recorded at fair market value at each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded on our consolidated statements of operations as other income or other expense. Once the criteria for conversion is fixed, the derivative instrument is marked to fair value and reclassified to equity.

Accounts Receivable and Allowance for Credit Losses

Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses. Credit is extended to customers based on an evaluation of their financial condition and other factors. We generally do not require collateral or other security to support accounts receivable. We perform ongoing credit evaluations of our customers and maintain an allowance for credit losses.

The allowance for credit losses is based on the best estimate of the amount of probable credit losses in existing accounts receivable. We assess credit losses on accounts receivable by taking into consideration past collection experience, the credit quality of the customer, the age of the receivable balance, current and future economic conditions, and forecasts that may affect the collectibility of the reported amount. In circumstances where we are aware of a specific customer’s inability to meet its financial obligations (e.g., bankruptcy filings or substantial downgrading of credit ratings), we record an allowance for credit losses in order to reduce the net recognized receivable to the amount we reasonably believe will be collected. For all other customers, we record an allowance for credit losses based on the length of time the receivable is past due and our historical experience of collections and write-offs.

The changes in the allowance for credit losses are as follows:


	Fiscal Year Ended July 31,
	2020			2021			2022
	(in thousands)
Allowance for credit losses—beginning balance	$	379		$	804		$	892
Charged to allowance for credit losses		822			655			200
Recoveries		(22	)		(286	)		(80	)
Write-offs		(375	)		(281	)		(368	)
Allowance for credit losses—ending balance	$	804		$	892		$	644

Property and Equipment

Property and equipment, including leasehold improvements, are stated at cost, less accumulated depreciation and amortization. We include the cost to acquire demonstration units and the related accumulated depreciation in property and equipment as such units are generally not available for sale. Depreciation and amortization is computed using the straight-line method over the estimated useful lives of the related assets.

Leases

We determine if an arrangement is or contains a lease at inception by evaluating various factors, including whether a vendor’s right to substitute an identified asset is substantive. Lease classification is determined at the lease commencement date when the leased assets are made available for our use. Operating leases are included in operating lease right-of-use assets, operating lease liabilities—current and operating lease liabilities—non-current in our consolidated balance sheet as of July 31, 2022. Finance leases are included in property and equipment, net, accrued expenses and other current liabilities and other liabilities—non-current in our consolidated balance sheet as of July 31, 2022.

Right-of-use assets ("ROU assets") represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make payments arising from the lease. ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Lease payments consist primarily of fixed payments under the arrangement, less any lease incentives, such as rent holidays. Variable lease payments not dependent on an index or a rate are expensed as incurred and are not included within the ROU asset and lease liability calculation. Variable lease payments primarily include reimbursements of costs incurred by lessors for common area maintenance, property taxes and utilities. We use an estimate of our incremental borrowing rate ("IBR") based on the information available at the lease commencement date in determining the present value of lease payments, unless the implicit rate is readily determinable. In determining the appropriate IBR, we consider information including, but not limited to, our credit rating, the lease term and the currency in which the arrangement is denominated. For leases which commenced prior to our adoption of Accounting Standards Update ("ASU") 2016-02, Leases ("ASC 842"), we used the IBR as of August 1, 2019. Our lease terms may include renewal options, which are not included in the lease terms for calculating our lease liability, as we are not reasonably certain that we will exercise these renewal options at the time of the lease commencement. Lease costs are recognized on a straight-line basis as operating expenses within our consolidated statements of operations. We present lease payments within cash flows from operations within our consolidated statements of cash flows.

For our operating leases, we account for lease and non-lease components as a single lease component. Additionally, we do not record leases on our consolidated balance sheet that have a lease term of 12 months or less at the lease commencement date.

Goodwill, Intangible Assets and Other Long-Lived Assets

Goodwill represents the future economic benefits arising from other assets acquired in a business combination or an acquisition that are not individually identified and separately recorded. The excess of the purchase price over the estimated fair value of net assets of businesses acquired in a business combination is recognized as goodwill.

Intangible assets consist of identifiable intangible assets, including developed technology, customer relationships and trade names, resulting from business combinations. Finite-lived intangible assets are recorded at fair value, net of accumulated amortization. Finite-lived intangible assets are amortized on a straight-line basis over their estimated useful lives. Amortization expense is included as a component of cost of product revenue and sales and marketing expense in the accompanying consolidated statements of operations. Amounts included in sales and marketing expense relate to customer relationships.

Goodwill and other intangible assets acquired in a business combination and determined to have an indefinite useful life are not amortized, but instead tested for impairment at least annually, as of May 1 of each year. Such goodwill and other intangible assets may also be tested for impairment between annual tests in the presence of impairment indicators such as, but not limited to: (i) a significant adverse change in legal factors or in the business climate; (ii) a substantial decline in our market capitalization; (iii) an adverse action or assessment by a regulator; (iv) unanticipated competition; (v) loss of key personnel; (vi) a more likely-than-not expectation of the sale or disposal of a reporting unit or a significant portion thereof; (vii) a realignment of our resources or restructuring of our existing businesses in response to changes to industry and market conditions; (viii) testing for recoverability of a significant asset group within a reporting unit; or (ix) a higher discount rate used in the impairment analysis as impacted by an increase in interest rates.

Goodwill is tested for impairment by comparing the reporting unit's carrying value, including goodwill, to the fair value of the reporting unit. We operate under one reporting unit and for our annual goodwill impairment test, we determine the fair value of our reporting unit based on our enterprise value. We may elect to utilize a qualitative assessment to determine whether it is more likely than not that the fair value of our reporting unit is less than its carrying value. If, after assessing the qualitative factors, we determine that it is more likely than not that the fair value of our reporting unit is less than its carrying value, an impairment analysis will be performed. We compare the fair value of our reporting unit with its carrying amount and if the carrying value of the reporting unit exceeds its fair value, an impairment loss will be recognized.

Long-lived assets, such as property and equipment and finite-lived intangible assets subject to depreciation and amortization, are evaluated for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. Among the factors and circumstances we consider in determining recoverability are: (i) a significant decrease in the market price of a long-lived asset; (ii) a significant adverse change in the extent or manner in which a long-lived asset is being used or in its physical condition; (iii) a significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset, including an adverse action or assessment by a regulator; (iv) an accumulation of costs significantly in excess of the amount originally expected for the acquisition; and (v) current-period operating or cash flow loss combined with a history of operating or cash flow losses or a projection or forecast that demonstrates continuing losses associated with the use of a long-lived asset. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset.

There have been no indicators of impairment of goodwill, intangible assets or other long-lived assets and we did not record any material impairment losses during fiscal 2020, 2021 or 2022.

Revenue Recognition

The core principle of ASC 606 is to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. This principle is achieved by applying the following five-step approach:

•

Identification of the contract, or contracts, with a customer — A contract with a customer exists when (i) we enter into an enforceable contract with a customer that defines each party’s rights regarding the goods or services to be transferred and identifies the payment terms related to these goods or services, (ii) the contract has commercial substance and (iii) we determine that collection of substantially all consideration for goods or services that are transferred is probable based on the customer’s intent and ability to pay the promised consideration. We apply judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors, including the customer’s historical payment experience or, in the case of a new customer, published credit and financial information pertaining to the customer.

•

Identification of the performance obligations in the contract — Performance obligations promised in a contract are identified based on the goods or services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the goods or services either on their own or together with other resources that are readily available from third parties or from us, and are distinct in the context of the contract, whereby the transfer of the goods or services is separately identifiable from other promises in the contract. To the extent a contract includes multiple promised goods or services, we apply judgment to determine whether promised goods or services are capable of being distinct and distinct in the context of the contract. If these criteria are not met, the promised goods or services are accounted for as a combined performance obligation.

•

Determination of the transaction price — The transaction price is determined based on the consideration to which we will be entitled in exchange for transferring goods or services to the customer.

•

Allocation of the transaction price to the performance obligations in the contract — If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price ("SSP"). We determine SSP based on the price at which the performance obligation is sold separately. If the SSP is not observable through past transactions, we estimate the SSP, taking into account available information such as market conditions and internally approved pricing guidelines related to the performance obligations.

•

Recognition of revenue when, or as, performance obligations are satisfied — We satisfy performance obligations either over time or at a point in time. Revenue is recognized at the time the related performance obligation is satisfied with the transfer of a promised good or service to a customer. For additional details on revenue recognition, refer to Note 2 of Notes to Consolidated Financial Statements.

Contracts with multiple performance obligations — The majority of our contracts with customers contain multiple performance obligations. For these contracts, we account for individual performance obligations separately if they are distinct. The transaction price is allocated to the separate performance obligations on a relative standalone selling price ("SSP") basis. For deliverables that we routinely sell separately, such as software entitlement and support subscriptions on our core offerings, we determine SSP by evaluating the standalone sales over the trailing 12 months. For those that are not sold routinely, we determine SSP based on our overall pricing trends and objectives, taking into consideration market conditions and other factors, including the value of our contracts, the products sold and geographic locations.

Contract balances — The timing of revenue recognition may differ from the timing of invoicing to customers. Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses. A receivable is recognized in the period we deliver goods or provide services, or when our right to consideration is unconditional. In situations where revenue recognition occurs before invoicing, an unbilled receivable is created, which represents a contract asset. Unbilled accounts receivable, included in accounts receivable, net on our consolidated balance sheets, was not material for any of the periods presented.

Payment terms on invoiced amounts are typically 30-45 days. We assess credit losses on accounts receivable by taking into consideration past collection experience, the credit quality of the customer, the age of the receivable balance, current and future economic conditions, and forecasts that may affect the collectibility of the reported amount. The balance of accounts receivable, net of allowance for credit losses, as of July 31, 2021 and 2022 is presented in the accompanying consolidated balance sheets.

Costs to obtain and fulfill a contract — We capitalize commissions paid to sales personnel and the related payroll taxes when customer contracts are signed. These costs are recorded as deferred commissions in our consolidated balance sheets, current and non-current. We determine whether costs should be deferred based on our sales compensation plans if the commissions are incremental and would not have been incurred absent the execution of the customer contract. Commissions paid upon the initial acquisition of a contract are recognized over the estimated period of benefit, which may exceed the term of the initial contract if the commissions expected to be paid upon renewal are not commensurate with that of the initial contract. Accordingly, deferred costs are recognized on a systematic basis that is consistent with the pattern of revenue recognition allocated to each performance obligation over the entire period of benefit and included in sales and marketing expense in our consolidated statements of operations. We determine the estimated period of benefit by evaluating the expected renewals of customer contracts, the duration of relationships with our customers, customer retention data, our technology development lifecycle and other factors. Deferred costs are periodically reviewed for impairment.

Taxes assessed by a government authority that are both imposed on and concurrent with specific revenue transactions between us and our customers are presented on a net basis in our consolidated statements of operations.

Deferred revenue — Deferred revenue primarily consists of amounts that have been invoiced but not yet recognized as revenue and primarily pertain to software entitlement and support subscriptions and professional services. The current portion of deferred revenue represents the amounts that are expected to be recognized as revenue within one year of the consolidated balance sheet date.

Cost of Revenue

Cost of revenue consists of cost of product revenue and cost of support, entitlements and other services revenue. Personnel costs associated with our operations and global customer support organizations consist of salaries, benefits and stock-based compensation. Allocated costs consist of certain facilities, depreciation and amortization, recruiting and information technology costs allocated based on headcount.

Warranties

We generally provide a one-year warranty on hardware sold by us and a 90-day warranty on software licenses. The hardware warranty provides for parts replacement for defective components and the software warranty provides for bug fixes. With respect to the hardware warranty obligation, we have a warranty agreement with our contract manufacturers under which the OEMs are generally required to replace defective hardware within three years of shipment. Furthermore, our post-contract customer support ("PCS") agreements provide for the same parts replacement that customers are entitled to under the warranty program, except that replacement parts are delivered according to targeted response times to minimize disruption to the customers’ critical business applications. Substantially all customers purchase PCS agreements.

Given the warranty agreement with our OEMs and considering that substantially all products are sold together with PCS agreements, we generally have very limited exposure related to warranty costs and therefore no warranty reserve has been recognized.

Research and Development

Our research and development expense consists primarily of product development personnel costs, including salaries and benefits, stock-based compensation and allocated facilities costs. Research and development costs are expensed as incurred. Currently, we expense the software development costs incurred in the research and development of new products and enhancements to existing products as incurred, as from the inception of the product development, our software products are primarily intended to be marketed and sold to customers on-premises, either standalone and/or with other product offerings.

Stock-Based Compensation

Stock-based compensation expense is measured based on the grant date fair value of share-based awards. The fair value of the purchase rights under our 2016 Employee Stock Purchase Plan ("2016 ESPP") is estimated using the Black-Scholes-Merton ("Black-Scholes") option pricing model, which is impacted by the fair value of our common stock, as well as changes in assumptions regarding a number of subjective variables. These variables include the expected common stock price volatility over the term of the awards, the expected term of the awards, risk-free interest rates and expected dividend yield. The fair value of restricted stock units ("RSUs") is determined using the fair value of our common stock on the date of grant.

We grant stock awards with service conditions only and with both service and performance or market-based conditions. We recognize stock-based compensation expense for employee stock awards with a service condition only using the straight-line method over the requisite service period of the awards, which is generally the vesting period. We use the graded vesting attribution method to recognize stock-based compensation expense related to employee stock awards that contain both service and performance or market-based conditions. The fair value of the 2016 ESPP purchase rights is recognized as expense on a straight-line basis over the offering period. We account for forfeitures of all share-based awards when they occur.

Foreign Currency

The functional currency of our foreign subsidiaries is the U.S. dollar. Transactions denominated in currencies other than the functional currency are remeasured at the average exchange rate in effect during the reporting period. At the end of each reporting period all monetary assets and liabilities of our subsidiaries are remeasured at the current U.S. dollar exchange rate at the end of the reporting period. Remeasurement gains and losses are included within other expense, net in the accompanying consolidated statements of operations. During the fiscal years ended July 31, 2020, 2021 and 2022, we recognized foreign currency losses of $9.4 million, $8.9 million and $3.2 million, respectively. To date, we have not undertaken any hedging transactions related to foreign currency exposure.

Segments

Our chief operating decision maker is a group which is comprised of our Chief Executive Officer and Chief Financial Officer. This group allocates resources and assesses financial performance based upon discrete financial information at the consolidated level. Accordingly, we have determined that we operate as a single operating and reportable segment.

Income Taxes

We account for income taxes using the asset and liability method. Deferred income taxes are recognized by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The measurement of deferred tax assets is reduced, if necessary, by a valuation allowance on amounts that are more likely than not to be realized.

We record a liability for uncertain tax positions if it is not more likely than not to be sustained based solely on its technical merits as of the reporting date. We consider many factors when evaluating and estimating our tax positions and tax benefits, which may require periodic adjustments and may not accurately anticipate actual outcomes.

Advertising Costs

Advertising costs are charged to sales and marketing expenses as incurred in our consolidated statements of operations. During the fiscal years ended July 31, 2020, 2021 and 2022, advertising expense was $38.7 million, $22.1 million and $13.7 million, respectively.

Recently Adopted Accounting Pronouncements

In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. Under ASU 2020-06, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in capital. Consequently, a convertible debt instrument will be accounted for as a single liability measured at its amortized cost and convertible preferred stock will be accounted for as a single equity instrument measured at its historical cost, as long as no other features require bifurcation and recognition as derivatives. By removing those separation models, the interest rate of convertible debt instruments typically will be closer to the coupon interest rate. ASU 2020-06 also provides for certain disclosures with regard to convertible instruments and associated fair values. We early adopted the new standard using the modified retrospective method effective August 1, 2021 and have not changed any previously disclosed amounts or provided additional disclosures for the comparative periods.

The adoption of this new guidance resulted in an increase in the carrying value of the 2023 Notes by approximately $48.0 million to reflect the full principal amount of the convertible notes outstanding, net of issuance costs, a decrease in additional paid-in capital of approximately $148.6 million to remove the equity component separately recorded for the conversion feature associated with the 2023 Notes, and a cumulative-effect adjustment of approximately $100.6 million to the accumulated deficit beginning balance as of August 1, 2021. The remaining debt issuance costs will continue to be amortized over the term of the 2023 Notes. The new standard had no impact on the 2026 Notes, as the embedded conversion feature on the 2026 Notes was initially accounted for as a derivative liability.

In May 2021, the FASB issued ASU 2021-04, Issuer's Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options, which provides guidance on modifications or exchanges of a freestanding equity-classified written call option (such as warrants). An entity should treat a modification of the terms or conditions or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange as an exchange of the original instrument for a new instrument, and provides further guidance on measuring the effect of a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange. ASU 2021-04 also provides guidance on the recognition of the effect of a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange on the basis of the substance of the transaction, in the same manner as if cash had been paid as consideration. The new standard is effective for all entities for fiscal years beginning after December 15, 2021, with early adoption permitted, including interim periods within those fiscal years. We early adopted the new standard effective August 1, 2021 and the adoption did not have a material impact on our consolidated financial statements.

Revenue, Deferred Revenue and Deferred Commissions

12 Months Ended

Jul. 31, 2022

Revenue Recognition and Deferred Revenue [Abstract]

Revenue, Deferred Revenue and Deferred Commissions

NOTE 2. REVENUE, DEFERRED REVENUE AND DEFERRED COMMISSIONS

Disaggregation of Revenue and Revenue Recognition

We generate revenue primarily from the sale of our enterprise cloud platform, which can be delivered pre-installed on an appliance that is configured to order or delivered separately to be utilized on a variety of certified hardware platforms. When the software license is not portable to other appliances, it can be used over the life of the associated appliance, while subscription term-based licenses typically have a term of one to five years. Configured-to-order appliances, including our Nutanix-branded NX hardware line, can be purchased from one of our OEMs or, in limited cases, directly from Nutanix. Our enterprise cloud platform typically includes one or more years of support and entitlements, which provides customers with the right to software upgrades and enhancements as well as technical support. A substantial portion of sales are made through channel partners and OEM relationships.

The following table depicts the disaggregation of revenue by revenue type, consistent with how we evaluate our financial performance:


	Fiscal Year Ended July 31,
	2020		2021		2022
	(in thousands)
Subscription	$	1,030,180	$	1,243,621	$	1,433,773
Non-portable software		208,158		71,390		49,694
Hardware		23,455		6,259		5,585
Professional services		45,889		73,094		91,744
Total revenue	$	1,307,682	$	1,394,364	$	1,580,796

Subscription revenue — Subscription revenue includes any performance obligation which has a defined term and is generated from the sales of software entitlement and support subscriptions, subscription software licenses and cloud-based software as a service ("SaaS") offerings.

•

Ratable — We recognize revenue from software entitlement and support subscriptions and SaaS offerings ratably over the contractual service period, the substantial majority of which relate to software entitlement and support subscriptions. These offerings represented approximately $508.8 million, $639.3 million and $770.4 million of our subscription revenue for fiscal 2020, 2021 and 2022, respectively.

•

Upfront — Revenue from our subscription software licenses is generally recognized upfront upon transfer of control to the customer, which happens when we make the software available to the customer. These subscription software licenses represented approximately $521.3 million, $604.3 million and $663.4 million of our subscription revenue for fiscal 2020, 2021 and 2022, respectively.

Non-portable software revenue — Non-portable software revenue includes sales of our enterprise cloud platform when delivered on a configured-to-order appliance by us or one of our OEM partners. The software licenses associated with these sales are typically non-portable and can be used over the life of the appliance on which the software is delivered. Revenue from our non-portable software products is generally recognized upon transfer of control to the customer.

Hardware revenue — In transactions where the hardware appliance is purchased directly from Nutanix, we consider ourselves to be the principal in the transaction and we record revenue and costs of goods sold on a gross basis. We consider the amount allocated to hardware revenue to be equivalent to the cost of the hardware procured. Hardware revenue is generally recognized upon transfer of control to the customer.

Professional services revenue — We also sell professional services with our products. We recognize revenue related to professional services as they are performed.

Significant changes in the balance of deferred revenue (contract liability) and deferred commissions (contract asset) for the periods presented are as follows:


	Deferred Revenue			Deferred Commissions
	(in thousands)
Balance as of July 31, 2020	$	1,183,441		$	215,528
Additions (1)		1,523,846			310,966
Revenue/commissions recognized		(1,394,364	)		(183,074	)
Balance as of July 31, 2021		1,312,923			343,420
Additions (1)		1,713,411			229,524
Revenue/commissions recognized		(1,580,796	)		(205,354	)
Balance as of July 31, 2022	$	1,445,538		$	367,590

(1)

Includes both billed and unbilled amounts.

During the fiscal year ended July 31, 2021, we recognized revenue of approximately $488.2 million pertaining to amounts deferred as of July 31, 2020. During the fiscal year ended July 31, 2022, we recognized revenue of approximately $592.6 million pertaining to amounts deferred as of July 31, 2021.

Many of our contracted but not invoiced performance obligations are subject to cancellation terms. Revenue allocated to remaining performance obligations represents contracted revenue that has not yet been recognized ("contracted not recognized"), which includes deferred revenue and non-cancelable amounts that will be invoiced and recognized as revenue in future periods and excludes performance obligations that are subject to cancellation terms. Contracted not recognized revenue was approximately $1.6 billion as of July 31, 2022, of which we expect to recognize approximately 54% over the next 12 months, and the remainder thereafter.

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI https://asc.fasb.org/topic&trid=49130388

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

+ Details

Fair Value Measurements

12 Months Ended

Jul. 31, 2022

Fair Value Disclosures [Abstract]

Fair Value Measurements

NOTE 3. FAIR VALUE MEASUREMENTS

The authoritative guidance on fair value measurements establishes a three-tier fair value hierarchy based on the observability of the inputs available in the market used to measure fair value as follows:

•

Level I — Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;

•

Level II — Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and

•

Level III — Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.

Assets Measured at Fair Value on a Recurring Basis

Cash equivalents and short-term investments

Our money market funds are classified within Level I due to the highly liquid nature of these assets and have unadjusted inputs, quoted prices in active markets for these assets at the measurement date from the financial institution that carries these investment securities. Our investments in available-for-sale debt securities such as commercial paper, corporate bonds and U.S. government securities are classified within Level II. The fair value of these securities is priced by using inputs based on non-binding market consensus prices that are corroborated by observable market data, quoted market prices for similar instruments, or pricing models such as discounted cash flow techniques.

The fair value of our financial assets measured on a recurring basis is as follows:


	As of July 31, 2021
	Level I		Level II		Level III		Total
	(in thousands)
Financial Assets:
Cash equivalents:
Money market funds	$	72,583	$	—	$	—	$	72,583
Commercial paper		—		29,997		—		29,997
Corporate bonds		—		2,002		—		2,002
Short-term investments:
Corporate bonds		—		513,688		—		513,688
Commercial paper		—		347,088		—		347,088
U.S. Government securities		—		67,230		—		67,230
Total measured at fair value	$	72,583	$	960,005	$	—	$	1,032,588
Cash								181,141
Total cash, cash equivalents and short-term investments							$	1,213,729


	As of July 31, 2022
	Level I		Level II		Level III		Total
	(in thousands)
Financial Assets:
Cash equivalents:
Money market funds	$	227,796	$	—	$	—	$	227,796
Commercial paper		—		27,927		—		27,927
Short-term investments:
Corporate bonds		—		409,024		—		409,024
Commercial paper		—		317,738		—		317,738
U.S. Government securities		—		194,667		—		194,667
Total measured at fair value	$	227,796	$	949,356	$	—	$	1,177,152
Cash								147,127
Total cash, cash equivalents and short-term investments							$	1,324,279

Financial Instruments Not Recorded at Fair Value on a Recurring Basis

We report our financial instruments at fair value, with the exception of the 2023 Notes, the 2026 Notes and the 2027 Notes (collectively, the "Notes"). Financial instruments that are not recorded at fair value on a recurring basis are measured at fair value on a quarterly basis for disclosure purposes. The carrying values and estimated fair values of financial instruments not recorded at fair value are as follows:


	As of July 31, 2021 (1)				As of July 31, 2022
	Carrying Value		Estimated Fair Value		Carrying Value		Estimated Fair Value
	(in thousands)
2023 Notes	$	523,671	$	602,272	$	145,456	$	143,154
2026 Notes		532,023		1,128,953		589,200		759,086
2027 Notes (2)		—		—		567,005		400,252
Total	$	1,055,694	$	1,731,225	$	1,301,661	$	1,302,492

(1)

Prior period amounts have not been adjusted due to our adoption of ASU 2020-06 under the modified retrospective method. For additional information on our adoption of ASU 2020-06, refer to Note 1 and Note 5.

(2)

The 2027 Notes were issued in September 2021.

The carrying value of the 2023 Notes as of July 31, 2021 was net of an unamortized debt discount of $48.6 million and unamortized debt issuance costs of $2.7 million, respectively. The carrying value of the 2023 Notes as of July 31, 2022 was net of unamortized debt issuance costs of $0.2 million.

The carrying value of the 2026 Notes as of July 31, 2021 and 2022 included $8.9 million and $28.0 million, respectively, of non-cash interest expense that was converted to the principal balance, net of unamortized debt discounts of $203.6 million and $169.4 million, respectively, and unamortized debt issuance costs of $23.3 million and $19.4 million, respectively.

The carrying value of the 2027 Notes as of July 31, 2022 was net of unamortized debt issuance costs of $8.0 million.

The total estimated fair value of the 2023 Notes was determined based on the closing trading price per $100 of the 2023 Notes as of the last day of trading for the period. We consider the fair value of the 2023 Notes to be a Level 2 valuation due to the limited trading activity.

The total estimated fair value of the 2026 Notes is based on a binomial model. We consider the fair value of the 2026 Notes to be a Level 3 valuation, as the 2026 Notes are not publicly traded. The Level 3 inputs used are the same as those used to determine the estimated fair value of the associated derivative liability, as detailed below.

The total estimated fair value of the 2027 Notes was determined based on the closing trading price per $100 of the 2027 Notes as of the last day of trading for the period. We consider the fair value of the 2027 Notes to be a Level 2 valuation due to the limited trading activity.

Derivative Liability

The conversion feature of the 2026 Notes represented an embedded derivative at inception. The 2026 Notes are not considered to be conventional debt and we determined that the embedded conversion feature was required to be bifurcated from the host debt and accounted for as a derivative liability, as the 2026 Notes were convertible into a variable number of shares until the conversion price became fixed in September 2021, based on the level of achievement of the associated financial performance metric. As such, the initial fair value of the derivative instrument was recorded as a liability in our consolidated balance sheet with the corresponding amount recorded as a discount to the 2026 Notes upon issuance. The derivative liability is considered a Level 3 valuation and was recorded at its estimated fair value at the end of each reporting period and as of September 15, 2021, when the conversion price became fixed, with the change in fair value recognized within other expense, net in our consolidated statements of operations.

On September 15, 2021, the conversion price of the 2026 Notes became fixed and the bifurcated liability was no longer accounted for as a separate derivative because the conversion features are now considered indexed to our own equity and meet the equity classification conditions. We estimated the fair value of the derivative liability as of September 15, 2021 to be $698.2 million, which was reclassified to equity on that date.

The following table shows the change in the estimated fair value of the derivative liability through October 31, 2021. There was no change to the estimated fair value of the derivative liability subsequent to October 31, 2021, as it was reclassified to equity.


	Three Months Ended October 31, 2021
	(in thousands)
Derivative liability at July 31, 2021	$	500,175
Change in fair value		198,038
Derivative liability at September 15, 2021		698,213
Reclass to equity upon conversion price becoming fixed		(698,213	)
Derivative liability at October 31, 2021	$	—

We estimated the fair value of the derivative liability using a binomial model, with the following valuation inputs:


	As of
	July 31, 2021	September 15, 2021
Conversion ratio (1)	Conversion price of $27.75 with a 36.036 conversion rate per $1,000	Conversion price of $27.75 with a 36.036 conversion rate per $1,000
Risk-free rate	0.7%	0.8%
Discount rate (2)	6.5%	6.5%
Volatility	40.0%	45.0%
Stock price	$36.02	$42.77

(1)

The conversion ratio was calculated based on the achievement of the associated financial performance metric.

(2)

The discount rate was estimated based on the implied rate for the 2023 Notes as well as a credit analysis.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Balance Sheet Components

12 Months Ended

Jul. 31, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Balance Sheet Components

NOTE 4. BALANCE SHEET COMPONENTS

Short-Term Investments

The amortized cost of our short-term investments approximates their fair value. Unrealized losses related to our short-term investments are generally due to interest rate fluctuations, as opposed to credit quality. However, we review individual securities that are in an unrealized loss position in order to evaluate whether or not they have experienced or are expected to experience credit losses that would result in a decline in fair value. As of July 31, 2021 and 2022, unrealized gains and losses from our short-term investments were not material and were not the result of a decline in credit quality. As a result, at July 31, 2021 and 2022, we did not record any credit losses for these investments.

The following table summarizes the estimated fair value of our investments in marketable debt securities by their contractual maturity dates:


	As of July 31, 2022
	(in thousands)
Due within one year	$	770,454
Due in one to two years		150,975
Total	$	921,429

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consists of the following:


	As of July 31,
	2021		2022
	(in thousands)
Prepaid operating expenses	$	36,455	$	48,842
VAT receivables		8,290		7,514
Other current assets		12,071		37,431
Total prepaid expenses and other current assets	$	56,816	$	93,787

The increase in other current assets from July 31, 2021 to July 31, 2022 was due primarily to the addition of a receivable for the estimated recovery of our settlement offer and certain legal fees and professional expenses payable under our applicable insurance policies related to certain litigation matters, as well as the addition of tenant improvement allowances receivable within the next 12 months.

Property and Equipment, Net

Property and equipment, net consists of the following:


	Estimated	As of July 31,
	Useful Life	2021			2022
	(in months)	(in thousands)
Computer, production, engineering and other equipment	36	$	300,583		$	341,536
Demonstration units	12		68,992			61,914
Leasehold improvements	(1)		62,676			61,443
Furniture and fixtures	60		16,518			16,508
Total property and equipment, gross			448,769			481,401
Less: accumulated depreciation (2)			(317,148	)		(367,961	)
Total property and equipment, net		$	131,621		$	113,440

(1)

Leasehold improvements are amortized over the shorter of the estimated useful lives of the improvements or the remaining lease term.

(2)

Includes a $0.9 million write-off related to the impairment of certain leasehold improvements during the fiscal year ended July 31, 2021. For additional information on this lease-related impairment, refer to Note 6.

Depreciation expense related to our property and equipment was $76.4 million, $76.5 million and $69.3 million for the fiscal years ended July 31, 2020, 2021 and 2022, respectively.

Intangible Assets, Net

Intangible assets, net consists of the following:


	As of July 31,
	2021			2022
	(in thousands)
Developed technology	$	79,300		$	79,300
Customer relationships		8,860			8,860
Trade name		4,170			4,170
Total intangible assets, gross		92,330			92,330
Less:
Accumulated amortization of developed technology		(50,764	)		(64,344	)
Accumulated amortization of customer relationships		(6,513	)		(8,074	)
Accumulated amortization of trade name		(3,041	)		(4,083	)
Total accumulated amortization		(60,318	)		(76,501	)
Total intangible assets, net	$	32,012		$	15,829

Amortization expense related to our intangible assets is being recognized in our consolidated statements of operations within product cost of revenue for developed technology and sales and marketing expense for customer relationships and trade name.

The changes in the net book value of intangible assets, net are as follows:


	As of July 31,
	2021			2022
	(in thousands)
Intangible assets, net—beginning balance	$	49,392		$	32,012
Amortization of intangible assets (1)		(17,380	)		(16,183	)
Intangible assets, net—ending balance	$	32,012		$	15,829

(1)

Represents amortization expense related to intangible assets recognized during the year in our consolidated statements of operations, within product cost of revenue and sales and marketing expense.

The estimated future amortization expense of our intangible assets is as follows:


Fiscal Year Ending July 31:	Amount
	(in thousands)
2023	$	10,856
2024		3,210
2025		1,763
Total	$	15,829

Goodwill

There was no change in the carrying amount of goodwill during the fiscal years ended July 31, 2021 or 2022.

Accrued Compensation and Benefits

Accrued compensation and benefits consists of the following:


	As of July 31,
	2021		2022
	(in thousands)
Accrued commissions	$	48,321	$	32,886
Accrued vacation		26,961		23,140
Payroll taxes payable		21,603		21,060
Accrued wages and taxes		1,675		20,807
Contributions to ESPP withheld		26,735		19,174
Accrued benefits		10,243		11,774
Accrued bonus		14,878		9,782
Other		11,921		11,188
Total accrued compensation and benefits	$	162,337	$	149,811

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consists of the following:


	As of July 31,
	2021		2022
	(in thousands)
Income taxes payable	$	13,309	$	13,206
Accrued professional services		3,541		5,499
Other		22,554		30,527
Total accrued expenses and other current liabilities	$	39,404	$	49,232

Convertible Senior Notes

12 Months Ended

Jul. 31, 2022

Debt Disclosure [Abstract]

Convertible Senior Notes

NOTE 5. CONVERTIBLE SENIOR NOTES

2023 Notes

In January 2018, we issued the 2023 Notes with a 0% interest rate for an aggregate principal amount of $575.0 million, due in 2023, in a private placement to qualified institutional buyers pursuant to Rule144A under the Securities Act. This included $75.0 million in aggregate principal amount of the 2023 Notes that we issued resulting from initial purchasers fully exercising their option to purchase additional notes. There are no required principal payments on the 2023 Notes prior to their maturity. The total net proceeds from the issuance of the 2023 Notes were as follows:


	Amount
	(in thousands)
Principal amount	$	575,000
Less: initial purchasers' discount		(10,781	)
Less: cost of the bond hedges		(143,175	)
Add: proceeds from the sale of warrants		87,975
Less: other issuance costs		(707	)
Net proceeds	$	508,312

The 2023 Notes do not bear any interest and will mature on January 15, 2023, unless earlier converted or repurchased in accordance with their terms. The 2023 Notes are unsecured and do not contain any financial covenants or any restrictions on the payment of dividends, or the issuance or repurchase of securities by us.

Each $1,000 of principal of the 2023 Notes is initially convertible into 20.4705 shares of our Class A common stock, which is equivalent to an initial conversion price of approximately $48.85 per share, subject to adjustment upon the occurrence of specified events. Holders of these 2023 Notes may convert their 2023 Notes at their option at any time prior to the close of the business day immediately preceding October 15, 2022, only under the following circumstances:

during any fiscal quarter commencing after the fiscal quarter ending on April 30, 2018 (and only during such fiscal quarter), if the last reported sale price of our Class A common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter, is greater than or equal to 130% of the conversion price on each applicable trading day;

during the five business day period after any five consecutive trading day period (the "measurement period") in which the trading price per $1,000 principal amount of 2023 Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our Class A common stock and the conversion rate for the 2023 Notes on each such trading day; or

upon the occurrence of certain specified corporate events.

Based on the closing price of our Class A common stock of $15.13 on July 31, 2022, the if-converted value of the 2023 Notes was lower than the principal amount. The price of our Class A common stock was not greater than or equal to 130% of the conversion price for 20 or more trading days during the 30 consecutive trading days ending on the last trading day of the quarter ended July 31, 2022. As such, the 2023 Notes are not convertible for the fiscal quarter commencing after July 31, 2022.

On or after October 15, 2022, holders may convert all or any portion of their 2023 Notes at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date, regardless of the foregoing conditions.

Upon conversion of the 2023 Notes, we will pay or deliver, as the case may be, cash, shares of our Class A common stock or a combination of cash and shares of Class A common stock, at our election. We intend to settle the principal of the 2023 Notes in cash.

The conversion rate will be subject to adjustment in some events, but will not be adjusted for any accrued or unpaid interest. A holder who converts their 2023 Notes in connection with certain corporate events that constitute a "make-whole fundamental change" per the indenture governing the 2023 Notes are, under certain circumstances, entitled to an increase in the conversion rate. In addition, if we undergo a fundamental change prior to the maturity date, holders may require us to repurchase for cash all or a portion of their 2023 Notes at a repurchase price equal to 100% of the principal amount of the repurchased 2023 Notes, plus accrued and unpaid interest.

We may not redeem the 2023 Notes prior to the maturity date, and no sinking fund is provided for the 2023 Notes.

On September 22, 2021, we consummated privately negotiated exchanges with certain holders of the outstanding 2023 Notes, pursuant to which such holders exchanged approximately $416.5 million in aggregate principal amount of 2023 Notes for $477.3 million in aggregate principal amount of 2027 Notes. We also entered into privately negotiated transactions with certain holders of the 2023 Notes pursuant to which we repurchased approximately $12.8 million in aggregate principal amount of 2023 Notes for cash. Following the closing of these exchanges and repurchases, approximately $145.7 million in aggregate principal amount of 2023 Notes remains outstanding with terms unchanged.

The 2023 Notes consisted of the following:


	As of July 31,
	2021			2022
	(in thousands)
Principal amounts:
Principal	$	575,000		$	145,704
Unamortized debt discount (1)		(48,616	)		—
Unamortized debt issuance costs (1)		(2,713	)		(248	)
Net carrying amount	$	523,671		$	145,456
Carrying amount of equity component (2)	$	148,598		$	—

(1)

Included in our consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2023 Notes using the effective interest rate method. As of July 31, 2021, the effective interest rate was 6.62%. As of July 31, 2022, the effective interest rate was 0.41%.

(2)

Included in our consolidated balance sheets as of July 31, 2021 within additional paid-in capital, net of $3.0 million in equity issuance costs.

As of July 31, 2022, the remaining life of the 2023 Notes was approximately 5 months.

The following table sets forth the total interest expense recognized related to the 2023 Notes:


	Fiscal Year Ended July 31,
	2020		2021		2022
	(in thousands)
Interest expense related to amortization of debt discount	$	29,658	$	31,682	$	—
Interest expense related to amortization of debt issuance costs		1,654		1,767		844
Total interest expense	$	31,312	$	33,449	$	844

Note Hedges and Warrants

Concurrently with the offering of the 2023 Notes in January 2018, we entered into convertible note hedge transactions with certain bank counterparties, whereby we have the initial option to purchase a total of approximately 11.8 million shares of our Class A common stock at a conversion price of approximately $48.85 per share, subject to adjustment for certain specified events. The total cost of the convertible note hedge transactions was approximately $143.2 million. In addition, we sold warrants to certain bank counterparties, whereby the holders of the warrants have the initial option to purchase a total of approximately 11.8 million shares of our Class A common stock at a price of $73.46 per share, subject to adjustment for certain specified events. We received approximately $88.0 million in cash proceeds from the sale of these warrants.

Taken together, the purchase of the convertible note hedges and the sale of warrants are intended to offset any actual dilution from the conversion of the 2023 Notes and to effectively increase the overall conversion price from $48.85 to $73.46 per share. As these transactions meet certain accounting criteria, the convertible note hedges and warrants are recorded within stockholders’ equity and are not accounted for as derivatives. The net cost incurred in connection with the convertible note hedge and warrant transactions of approximately $55.2 million was recorded as a reduction to additional paid-in capital in our consolidated balance sheets as of July 31, 2021 and 2022. The fair value of the note hedges and warrants are not remeasured each reporting period. The amounts paid for the note hedges were tax deductible expenses, while the proceeds received from the warrants were not taxable.

In September 2021, in connection with the exchange and repurchase transactions described above, we terminated portions of the convertible note hedge transactions and warrant transactions previously entered into with certain financial institutions in connection with the issuance of the 2023 Notes. The net effect of these unwind transactions was a $21.5 million cash payment received, consisting of an $18.4 million payment for the warrant unwind and the receipt of $39.9 million from the hedge unwind. The amounts paid and received as part of the unwind transactions were recorded to additional paid-in capital within our consolidated balance sheet.

The note hedges are required to be excluded from the calculation of diluted earnings per share ("EPS"), as they would be antidilutive. In periods when we report a net loss, basic net loss per share and diluted net loss per share are the same, as the effect of potential common shares is antidilutive, and the potential impact of the 2023 Notes is therefore excluded.

The warrants will have a dilutive effect when the average share price exceeds the warrant strike price of $73.46 per share. As the price of our Class A common stock continues to increase above the warrant strike price, additional dilution would occur at a declining rate so that a $10 increase from the warrant strike price would yield a cumulative dilution of approximately 0.4 million diluted shares for EPS purposes. However, upon conversion, the note hedges would neutralize the dilution from the 2023 Notes so that there would only be dilution from the warrants, which would result in an actual dilution of approximately 2.1 million shares at a common stock price of $83.46.

2026 Notes

In September 2020, we issued $750.0 million in aggregate principal amount of the 2026 Notes to BCPE Nucleon (DE) SVP, LP, an entity affiliated with Bain Capital, LP ("Bain"). The total net proceeds from this offering were approximately $723.72 million, after deducting $26.3 million of debt issuance costs.

The 2026 Notes bear interest at a rate of 2.5% per annum, with such interest to be paid in kind ("PIK") on the 2026 Notes held by Bain through an increase in the principal amount of the 2026 Notes, and paid in cash on any 2026 Notes transferred to entities that are not affiliated with Bain. Interest on the 2026 Notes has accrued from the date of issuance (September 24, 2020) and is added to the principal amount on a semi-annual basis (on March 15 and September 15 of each year, beginning on March 15, 2021). The 2026 Notes mature on September 15, 2026, subject to earlier conversion, redemption or repurchase.

The 2026 Notes are convertible into our shares of Class A common stock based on an initial conversion rate of 36.036 shares of common stock per $1,000 principal amount of the 2026 Notes, which is equal to an initial conversion price of $27.75 per share, subject to customary anti-dilution and other adjustments, including in connection with any make-whole adjustments as a result of certain extraordinary transactions. In September 2021, the one-year anniversary of the issuance of the 2026 Notes, the conversion price was subject to a one-time adjustment, based on the level of achievement of certain financial milestones and as a result, the conversion price became fixed at $27.75 per share.

On or after September 15, 2025, the 2026 Notes will be redeemable by us in the event that the closing sale price of our Class A common stock has been at least 150% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide the redemption notice, for cash, at a redemption price of 100% of the principal amount of such 2026 Notes, plus any accrued and unpaid interest to, but excluding, the redemption date.

With certain exceptions, upon a change of control or a fundamental change, the holders of the 2026 Notes may require us to repurchase all or part of the principal amount of the 2026 Notes at a repurchase price equal to 100% of the principal amount of the 2026 Notes, plus any accrued and unpaid interest to, but excluding, the repurchase date. In addition, we will, in certain circumstances, increase the conversion rate for any 2026 Notes converted in connection with a change of control or a fundamental change.

In accordance with accounting guidance on embedded conversion features, we valued and bifurcated the conversion option associated with the 2026 Notes from the respective host debt instrument, which is treated as a debt discount, and initially recorded the conversion option of $230.9 million as a derivative liability in our consolidated balance sheet, with the corresponding amount recorded as a discount to the 2026 Notes to be amortized over the term of the 2026 Notes using the effective interest method.

The 2026 Notes consisted of the following:


	As of July 31,
	2021			2022
	(in thousands)
Principal amounts:
Principal	$	750,000		$	750,000
Non-cash interest expense converted to principal		8,906			27,997
Unamortized debt discount (conversion feature) (1)		(203,619	)		(169,438	)
Unamortized debt issuance costs (1)		(23,264	)		(19,359	)
Net carrying amount	$	532,023		$	589,200

(1)

Included in our consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2026 Notes using the effective interest rate method. The effective interest rate is 7.05%.

As of July 31, 2022, the remaining life of the 2026 Notes was approximately 4.1 years.

The following table sets forth the total interest expense recognized related to the 2026 Notes:


	Fiscal Year Ended July 31,
	2021		2022
	(in thousands)
Interest expense related to amortization of debt discount	$	27,291	$	34,180
Interest expense related to amortization of debt issuance costs		3,119		3,906
Non-cash interest expense		16,074		19,270
Total interest expense	$	46,484	$	57,356

Non-cash interest expense is related to the 2.5% PIK interest that we accrued from the issuance of the 2026 Notes through July 31, 2022 and was recognized within other expense, net in our consolidated statement of operations and other liabilities–non-current in our consolidated balance sheet. The accrued PIK interest will be converted to the principal balance of the 2026 Notes at each payment date and will be convertible to shares at maturity or when converted.

Upon the conversion price of the 2026 Notes becoming fixed in September 2021, the embedded conversion option for the 2026 Notes no longer required bifurcation because the conversion features are now considered indexed to our own equity and meet the equity classification conditions. The carrying amount of the derivative liability of $698.2 million as of that date was reclassified to additional paid-in capital within our consolidated balance sheet. The remaining debt discount that arose from the original bifurcation continues to be amortized over the term of the 2026 Notes.

2027 Notes

In September 2021, we issued $575 million principal amount of 0.25% convertible senior notes due 2027 consisting of (i) approximately $477.3 million principal amount of 2027 Notes in exchange for approximately $416.5 million principal amount of the 2023 Notes (the "Exchange Transactions") and (ii) approximately $97.7 million principal amount of 2027 Notes for cash (the "Subscription Transactions"). We did not receive any cash proceeds from the Exchange Transactions. The net cash proceeds from the Subscription Transactions was approximately $88.4 million after deducting the offering expenses for both the Exchange Transactions and the Subscription Transactions. We used (i) approximately $14.7 million of the net cash proceeds from the Subscription Transactions to repurchase approximately $12.8 million principal amount of the 2023 Notes and (ii) approximately $58.5 million of the net cash proceeds from the Subscription Transactions to repurchase approximately 1.4 million shares of our Class A common stock.

The 2027 Notes bear interest at a rate of 0.25% per annum, and pay interest semi-annually in arrears on each April 1 and October 1, commencing on April 1, 2022. The 2027 Notes will mature on October 1, 2027, unless earlier converted, redeemed or repurchased.

The 2027 Notes are convertible into cash, shares of our Class A common stock, or a combination of cash and shares of Class A common stock, at our election. Each $1,000 of principal of the 2027 Notes is initially convertible into 17.3192 shares of our Class A common stock, which is equivalent to an initial conversion price of approximately $57.74 per share, subject to customary anti-dilution adjustments. Holders of these 2027 Notes may convert their 2027 Notes at their option at any time prior to the close of the business day immediately preceding July 1, 2027, only under the following circumstances:

(1)

during any fiscal quarter after January 31, 2022, and only during such fiscal quarter, if the closing price of our common stock for at least 20 trading days in a period of 30 consecutive trading days ending on, and including, the last trading day of the preceding fiscal quarter is greater than or equal to 130% of the then applicable conversion price for the Notes per share of common stock;

(2)

during the five business day period after any five consecutive trading day period in which, for each trading day of that period, the trading price per $1,000 principal amount of 2027 Notes for such trading day was less than 98% of the product of the closing price of our common stock and the then applicable conversion rate on each such trading day; or

(3)

upon the occurrence of certain specified corporate events.

Upon conversion of the 2027 Notes, we will pay or deliver, as the case may be, cash, shares of our Class A common stock or a combination of cash and shares of Class A common stock, at our election. We intend to settle the principal of the 2027 Notes in cash.

The conversion rate will be subject to adjustment in some events, but will not be adjusted for any accrued or unpaid interest. A holder who converts their 2027 Notes in connection with certain corporate events that constitute a "make-whole fundamental change" per the indenture governing the 2027 Notes are, under certain circumstances, entitled to an increase in the conversion rate. In addition, if we undergo a fundamental change prior to the maturity date, holders may require us to repurchase for cash all or a portion of their 2027 Notes at a repurchase price equal to 100% of the principal amount of the repurchased 2027 Notes, plus accrued and unpaid interest.

In accounting for the exchange of convertible notes, we evaluated whether the transaction should be treated as a modification or extinguishment transaction. The partial exchange of the 2023 Notes and issuance of the 2027 Notes were deemed to have substantially different terms due to the significant difference between the value of the conversion option immediately prior to and after the exchange, and consequently, the 2023 Notes partial exchange was accounted for as a debt extinguishment. The $64.9 million difference between the total reacquisition price paid and the net carrying amount of the 2023 Notes is recognized as a debt extinguishment loss within other expense, net in our consolidated statement of operations.

The 2027 Notes consisted of the following:


	As of July 31, 2022
	(in thousands)
Principal amounts:
Principal	$	575,000
Unamortized debt issuance costs (1)		(7,995	)
Net carrying amount	$	567,005

(1)

Included in our consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2027 Notes using the effective interest rate method. The effective interest rate is 0.52%.

As of July 31, 2022, the remaining life of the 2027 Notes was approximately 5.2 years.

The following table sets forth the total interest expense recognized related to the 2027 Notes:


	Fiscal Year Ended July 31,
	2022
	(in thousands)
Contractual interest expense	$	1,229
Interest expense related to amortization of debt issuance costs		1,302
Total interest expense	$	2,531

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI https://asc.fasb.org/topic&trid=2208564

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1E
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (i)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

+ Details

Leases

12 Months Ended

Jul. 31, 2022

Leases [Abstract]

Leases

NOTE 6. LEASES

We have operating leases for offices, research and development facilities and datacenters and finance leases for certain datacenter equipment. Our leases have remaining lease terms of one year to approximately eight years, some of which include options to renew or terminate. We do not include renewal options in the lease terms for calculating our lease liability, as we are not reasonably certain that we will exercise these renewal options at the time of the lease commencement. Our lease agreements do not contain any residual value guarantees or restrictive covenants.

Total operating lease cost was $39.1 million, $42.6 million and $43.3 million for the fiscal years ended July 31, 2020, 2021 and 2022, respectively, excluding short-term lease costs, variable lease costs and sublease income, each of which were not material. Variable lease costs primarily include common area maintenance charges. Total finance lease cost was $0.7 million and $2.4 million for the fiscal years ended July 31, 2021 and 2022, respectively. We had no finance leases during the fiscal year ended July 31, 2020.

During fiscal 2020, we ceased using certain office spaces internationally. As the carrying value of the related right-of-use assets exceeded fair value, we recorded a $3.0 million impairment in our consolidated statements of operations for the fiscal year ended July 31, 2020. Of the $3.0 million impairment, approximately $1.8 million relates to the impairment of our operating lease right-of-use assets and approximately $1.2 million relates to the impairment of leasehold improvements.

During fiscal 2021, we recorded additional impairment charges related to certain international office spaces, as well as an impairment charge related to an office space in the United States. We recorded a $1.4 million net impairment in our consolidated statement of operations for the fiscal year ended July 31, 2021. Of the $1.4 million impairment, approximately $0.5 million relates to the impairment of our operating lease right-of-use assets and approximately $0.9 million relates to the impairment of leasehold improvements. Additional charges related to asset impairments may be recorded in the future.

During fiscal 2022, we signed agreements to early exit certain office spaces in the United States. The reduction in the lease term resulted in a decrease to the carrying amount of the operating lease liability and the operating lease right-of-use asset on our consolidated balance sheet as of July 31, 2022. In addition, we recorded $0.6 million of expense in our consolidated statement of operations for the fiscal year ended July 31, 2022.

Supplemental balance sheet information related to leases is as follows:


	As of July 31,
	2021			2022
	(in thousands)
Operating leases:
Operating lease right-of-use assets, gross	$	170,277		$	188,060
Accumulated amortization		(64,374	)		(69,320	)
Operating lease right-of-use assets, net	$	105,903		$	118,740
Operating lease liabilities—current	$	42,670		$	39,801
Operating lease liabilities—non-current		86,599			89,782
Total operating lease liabilities	$	129,269		$	129,583
Weighted average remaining lease term (in years):		3.1			5.1
Weighted average discount rate:		5.5	%		5.7	%


	As of July 31,
	2021			2022
	(in thousands)
Finance leases:
Finance lease right-of-use assets, gross (1)	$	8,972		$	13,501
Accumulated amortization (1)		(687	)		(3,053	)
Finance lease right-of-use assets, net (1)	$	8,285		$	10,448
Finance lease liabilities—current (2)	$	1,772		$	2,685
Finance lease liabilities—non-current (3)		6,527			7,806
Total finance lease liabilities	$	8,299		$	10,491
Weighted average remaining lease term (in years):		4.7			3.9
Weighted average discount rate:		6.7	%		5.9	%

(1)

Included in our consolidated balance sheets within property and equipment, net.

(2)

Included in our consolidated balance sheets within accrued expenses and other current liabilities.

(3)

Included in our consolidated balance sheets within other liabilities—non-current.

Supplemental cash flow and other information related to leases is as follows:


	Fiscal Year Ended July 31,
	2021		2022
	(in thousands)
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	46,216	$	48,509
Financing cash flows from finance leases	$	459	$	1,089
Lease liabilities arising from obtaining right-of-use assets:
Operating leases	$	16,174	$	55,797
Finance leases	$	9,622	$	4,529

The undiscounted cash flows for our lease liabilities as of July 31, 2022 were as follows:


Fiscal Year Ending July 31:	Operating Leases			Finance Leases			Total
	(in thousands)
2023	$	43,199		$	2,750		$	45,949
2024		30,393			2,750			33,143
2025		17,100			2,750			19,850
2026		13,805			2,048			15,853
2027		12,699			337			13,036
Thereafter		36,396			—			36,396
Total lease payments		153,592			10,635			164,227
Less: imputed interest		(24,009	)		(144	)		(24,153	)
Total lease obligation		129,583			10,491			140,074
Less: current lease obligations		(39,801	)		(2,685	)		(42,486	)
Long-term lease obligations	$	89,782		$	7,806		$	97,588

As of July 31, 2022, we had additional operating lease commitments of approximately $7.3 million on an undiscounted basis for certain office leases that have not yet commenced. These operating leases will commence during fiscal 2023, with lease terms of approximately three to eight years.

Commitments and Contingencies

12 Months Ended

Jul. 31, 2022

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

NOTE 7. COMMITMENTS AND CONTINGENCIES

Purchase Commitments

In the normal course of business, we make commitments with our contract manufacturers to ensure them a minimum level of financial consideration for their investment in our joint solutions. These commitments are based on performance targets or on-hand inventory and non-cancelable purchase orders for non-standard components. We record a charge related to these items when we determine that it is probable a loss will be incurred and we are able to estimate the amount of the loss. Our historical charges have not been material. As of July 31, 2022, we had up to approximately $88.7 million of non-cancelable purchase obligations and other commitments pertaining to our daily business operations, and up to approximately $82.3 million in the form of guarantees to certain of our contract manufacturers.

Guarantees and Indemnifications

We have entered into agreements with some of our Partners and customers that contain indemnification provisions in the event of claims alleging that our products infringe the intellectual property rights of a third party. The scope of such indemnification varies, and may include, in certain cases, the ability to cure the indemnification by modifying or replacing the product at our own expense, requiring the return and refund of the infringing product, procuring the right for the partner and/or customer to continue to use or distribute the product, as applicable, and/or defending the partner or customer against and paying any damages from third-party actions based upon claims of infringement. Other guarantees or indemnification arrangements include guarantees of product and service performance.

We have also agreed to indemnify our directors, executive officers and certain other officers for costs associated with any fees, expenses, judgments, fines and settlement amounts incurred by any of these persons in any action or proceeding to which any of those persons is, or is threatened to be, made a party by reason of the person’s service as a director or officer, including any action by us, arising out of that person’s services as a director or officer of our company or that person’s services provided to any other company or enterprise at our request. We maintain director and officer insurance coverage that may enable us to recover a portion of any future amounts paid.

The fair value of liabilities related to indemnifications and guarantee provisions are not material and have not had any material impact on our consolidated financial statements to date.

Legal Proceedings

Securities Class Actions. Beginning on March 29, 2019, several purported securities class actions were filed in the United States District Court for the Northern District of California against us and two of our officers. The initial complaints generally alleged that the defendants made false and misleading statements in violation of Sections 10(b) and 20(a) of the Exchange Act and SEC Rule 10b-5. In July 2019, the court consolidated the actions into a single action, and appointed a lead plaintiff, who then filed a consolidated amended complaint (the "Original Complaint"). The action was brought on behalf of those who purchased or otherwise acquired our stock between November 30, 2017 and May 30, 2019, inclusive. The defendants subsequently filed a motion to dismiss the Original Complaint, which the court granted on March 9, 2020, while providing the lead plaintiff leave to amend. On April 17, 2020, the lead plaintiff filed a second amended complaint (the "Amended Complaint"), again naming us and two of our officers as defendants. The Amended Complaint alleges the same class period, includes many of the same factual allegations as the Original Complaint, and again alleges that the defendants violated Sections 10(b) and 20(a) of the Exchange Act, as well as SEC Rule 10b-5. The Amended Complaint sought monetary damages in an unspecified amount. On September 11, 2020, the court denied the defendants' motion to dismiss the Amended Complaint and held that the lead plaintiff adequately stated a claim with respect to certain statements regarding our new customer growth and sales productivity. On January 27, 2021, lead plaintiff, Shimon Hedvat, filed a motion to (i) withdraw as lead plaintiff and (ii) substitute proposed new lead plaintiffs and approve their appointment of a new co-lead counsel. On March 1, 2021, the court granted the lead plaintiff’s motion to withdraw as lead plaintiff but denied without prejudice his motion to substitute proposed new lead plaintiffs. The court also reopened the lead plaintiff selection process, allowing any putative class member interested in serving as the new lead plaintiff to file a lead plaintiff application. Following the lead plaintiff selection hearing on April 28, 2021, on June 10, 2021 the court appointed California Ironworkers Field Pension Trust as lead plaintiff and approved its appointment of counsel. On May 28, 2021, one of the movants for lead plaintiff, John P. Norton on behalf of the Norton Family Living Trust UAD 11/15/2002, filed a separate class action complaint (the "Options Class Action Complaint") in the Northern District of California on behalf of a class of persons or entities who transacted in publicly traded call options and/or put options on Nutanix stock during the period from November 30, 2017 and May 30, 2019, containing allegations substantively the same as those alleged in the Amended Complaint (the "Options Class Action") and naming the same defendants. On September 8, 2021, the court appointed the John P. Norton on behalf of the Norton Family Living Trust UAD 11/15/2002 as the lead plaintiff in the Options Class Action. On April 26, 2022, the parties met for mediation, which did not result in a settlement. On September 1, 2022, California Ironworkers Field Pension Trust filed a third amended complaint (which amends the Amended Complaint) and John P. Norton on behalf of the Norton Family Living Trust UAD 11/15/2002 filed an amended complaint (which amends the Options Class Action Complaint). We plan to continue to vigorously defend against these actions. We recorded an accrual for estimated loss contingencies associated with this matter in an amount equal to a settlement offer we made at the mediation. The accrual does not reflect our views of the merits of claims in these actions. In addition, we recorded a corresponding receivable for the estimated recovery in respect of our settlement offer and certain legal fees and professional expenses payable under our applicable insurance policies. The accrual and estimated recovery may change in the future due to new developments, and the actual liability and recovery may vary significantly from current estimates.

We are not currently a party to any other legal proceedings that we believe to be material to our business or financial condition. From time to time, we may become party to various litigation matters and subject to claims that arise in the ordinary course of business.

Stockholders' Equity

12 Months Ended

Jul. 31, 2022

Equity [Abstract]

Stockholders' Equity

NOTE 8. STOCKHOLDERS’ EQUITY

As of July 31, 2022, we had 1.0 billion shares of Class A common stock authorized, with a par value of $0.000025 per share, and 42.0 million shares of Class B common stock authorized, with a par value of $0.000025 per share. As of July 31, 2022, we had 226.9 million shares of Class A common stock issued and outstanding and no shares of Class B common stock issued and outstanding.

Holders of Class A common stock are entitled to one vote for each share of Class A common stock held on all matters submitted to a vote of stockholders.

Share Repurchase

In August 2020, our Board of Directors authorized the repurchase of up to $125.0 million of our Class A common stock. Repurchases were made through open market purchases or privately negotiated transactions subject to market conditions, applicable legal requirements and other relevant factors. The repurchase program did not obligate us to acquire any particular amount of our common stock and could have been suspended at any time at our discretion.

During the fiscal year ended July 31, 2021, we repurchased 5.2 million shares of Class A common stock in open market transactions at an average price of $24.15 per share, for an aggregate purchase price of $125.0 million. As of July 31, 2021, there was no remaining authorization and the program had expired.

In September 2021, we used approximately $58.5 million of the net cash proceeds from the issuance of $97.7 million in aggregate principal amount of 2027 Notes to repurchase 1.4 million shares of Class A common stock in open market transactions at an average price of $42.77 per share. For additional details on these transactions, refer to Note 5.

Common Stock Reserved for Issuance

As of July 31, 2022, we had reserved shares of common stock for future issuance as follows:


	As of July 31, 2022
	(in thousands)
Shares reserved for future equity grants		15,159
Shares underlying outstanding stock options		1,689
Shares underlying outstanding restricted stock units		22,136
Shares reserved for future employee stock purchase plan awards		2,362
Total		41,346

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI https://asc.fasb.org/topic&trid=2208762

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 16
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (i)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 50
-Paragraph 6
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008

+ Details

Equity Incentive Plans

12 Months Ended

Jul. 31, 2022

Share-Based Payment Arrangement [Abstract]

Equity Incentive Plans

NOTE 9. EQUITY INCENTIVE PLANS

Stock Plans

We have three equity incentive plans, the 2010 Stock Plan ("2010 Plan"), 2011 Stock Plan ("2011 Plan") and 2016 Equity Incentive Plan ("2016 Plan"). Our stockholders approved the 2016 Plan in March 2016 and it became effective in connection with our initial public offering ("IPO"). As a result, at the time of the IPO, we ceased granting additional stock awards under the 2010 Plan and 2011 Plan and both plans were terminated. Any outstanding stock awards under the 2010 Plan and 2011 Plan remain outstanding, subject to the terms of the applicable plan and award agreements, until such shares are issued under those stock awards, by exercise of stock options or settlement of RSUs, or until those stock awards become vested or expired by their terms.

Under the 2016 Plan, we may grant incentive stock options, non-statutory stock options, restricted stock, RSUs and stock appreciation rights to employees, directors and consultants. We initially reserved 22.4 million shares of our Class A common stock for issuance under the 2016 Plan. The number of shares of Class A common stock available for issuance under the 2016 Plan will also include an annual increase on the first day of each fiscal year, beginning in fiscal 2018, equal to the lesser of: 18.0 million shares, 5% of the outstanding shares of all classes of common stock as of the last day of our immediately preceding fiscal year, or such other amount as may be determined by the Board. Accordingly, on August 1, 2020 and 2021, the number of shares of Class A common stock available for issuance under the 2016 Plan increased by 10.1 million and 10.7 million shares, respectively, pursuant to these provisions. As of July 31, 2022, we had reserved a total of 39.0 million shares for the issuance of equity awards under the Stock Plans, of which 15.2 million shares were still available for grant. On August 1, 2022, the number of shares of Class A common stock available for issuance under the 2016 Plan increased by 11.3 million shares pursuant to the automatic increase provisions.

Restricted Stock Units

Performance RSUs — We have granted RSUs that have both service and performance conditions to our executives and employees ("Performance RSUs"). Vesting of Performance RSUs is subject to continuous service and the satisfaction of certain performance targets. While we recognize cumulative stock-based compensation expense for the portion of the awards for which both the service condition has been satisfied and it is probable that the performance conditions will be met, the actual vesting and settlement of Performance RSUs are subject to the performance conditions actually being met.

Market Stock Units

In connection with his hiring, in December 2020, the Compensation Committee of our Board of Directors approved the grant of 703,117 RSUs subject to certain market conditions ("MSUs") to our President and CEO. These MSUs have a weighted average grant date fair value per unit of $35.69 and will vest up to 133% based upon the achievement of certain stock price targets over a performance period of approximately 4.0 years, subject to his continuous service on each vesting date.

In order to align with the MSUs granted to our President and CEO, in December 2020, the Compensation Committee of our Board of Directors modified the vesting conditions for the 75,000 MSUs previously granted to another individual who was then serving as one of our executives. These modified MSUs had a weighted average grant date fair value per unit of $27.54 and vested based upon the achievement of a modified stock price target over the original performance period of approximately 3.9 years, subject to continuous service on each vesting date. The incremental compensation cost resulting from this modification was not material. Following the individual's resignation during the second quarter of fiscal 2022, his remaining unvested MSUs were cancelled.

In October 2021, the Compensation Committee of our Board of Directors approved the grant of approximately 0.4 million MSUs to certain of our executives. These MSUs have a weighted average grant date fair value per unit of $46.20 and will vest up to 200% of the target number of MSUs based upon our total shareholder return relative to the total shareholder return of companies in the Nasdaq Composite Index over a performance period of approximately 2.8 years, subject to continuous service on each vesting date. Additional MSUs have been granted with similar terms, but were not material.

We used Monte Carlo simulations to calculate the fair value of these awards on the grant date, or modification date, as applicable. A Monte Carlo simulation requires the use of various assumptions, including the stock price volatility and risk-free interest rate as of the valuation date corresponding to the length of time remaining in the performance period and expected dividend yield. We recognize stock-based compensation expense related to these MSUs using the graded vesting attribution method over the respective performance periods. As of July 31, 2022, approximately 1.1 million MSUs remained outstanding.

Below is a summary of RSU activity, including MSUs, under the Stock Plans:


	Fiscal Year Ended July 31,
	2021					2022
	Number of Shares			Weighted Average Grant Date Fair Value per Share		Number of Shares			Weighted Average Grant Date Fair Value per Share
	(in thousands)
Outstanding at beginning of period		22,632		$	32.70		21,708		$	30.98
Granted		13,732		$	29.60		15,575		$	30.92
Released		(9,744	)	$	32.58		(9,626	)	$	32.68
Forfeited		(4,912	)	$	31.87		(5,521	)	$	32.55
Outstanding at end of period		21,708		$	30.98		22,136		$	29.81

The aggregate grant date fair value of RSUs, including MSUs, vested was $298.2 million, $317.4 million and $314.6 million for the fiscal years ended July 31, 2020, 2021 and 2022, respectively.

Stock Options

The Board determines the period over which stock options become exercisable and stock options generally vest over a four-year period. Stock options generally expire 10 years from the date of grant. The term of an ISO grant to a 10% stockholder will not exceed five years from the date of the grant. The exercise price of an ISO will not be less than 100% of the estimated fair value of the shares of common stock underlying the stock option (or 110% of the estimated fair value in the case of an ISO granted to a 10% stockholder) on the date of grant. The exercise price of an NSO is determined by the Board at the time of grant and is generally not less than 100% of the estimated fair value of the shares of common stock underlying the stock option on the date of grant.

Below is a summary of stock option activity under the Stock Plans:


	Fiscal Year Ended July 31,
	2021									2022
	Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life		Aggregate Intrinsic Value		Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life		Aggregate Intrinsic Value
	(in thousands)					(in years)		(in thousands)		(in thousands)					(in years)		(in thousands)
Outstanding at beginning of period		7,546		$	5.10		3.6	$	129,010		3,334		$	5.20		2.8	$	102,740
Options granted		—		$	—						—		$	—
Options exercised		(3,712	)	$	4.07						(1,643	)	$	3.94
Options canceled/forfeited		(500	)	$	12.00						(2	)	$	13.04
Outstanding at end of period		3,334		$	5.20		2.8	$	102,740		1,689		$	6.43		1.9	$	14,707
Exercisable at end of period		3,334		$	5.20		2.8	$	102,739		1,689		$	6.43		1.9	$	14,707

The aggregate intrinsic value of stock options exercised during the fiscal years ended July 31, 2020, 2021 and 2022 was $23.4 million, $90.5 million and $35.0 million, respectively. Aggregate intrinsic value represents the difference between the exercise price of the options and the estimated fair value of our common stock. Cash received from option exercises was $6.9 million, $15.1 million and $6.5 million for the fiscal years ended July 31, 2020, 2021 and 2022, respectively. The total grant date fair value of stock options vested was $1.0 million and $0.2 million for the fiscal years ended July 31, 2020 and 2021, respectively. The total grant date fair value of stock options vested was not material for the fiscal year ended July 31, 2022. We did not grant any stock options during the fiscal years ended July 31, 2020, 2021 or 2022.

Employee Stock Purchase Plan

In December 2015, the Board adopted the 2016 Employee Stock Purchase Plan, which was subsequently amended in January 2016 and September 2016 and approved by our stockholders in March 2016 (the "Original 2016 ESPP"). The Original 2016 ESPP became effective in connection with our IPO. On December 13, 2019, our stockholders approved certain amendments to the Original 2016 ESPP. Under the amended and restated Original 2016 ESPP (the "2016 ESPP"), the maximum number of shares of Class A common stock available for sale is 11.5 million shares, representing an increase of 9.2 million shares.

The 2016 ESPP allows eligible employees to purchase shares of our Class A common stock at a discount through payroll deductions of up to 15% of eligible compensation, subject to caps of $25,000 in any calendar year and 1,000 shares on any purchase date. The 2016 ESPP provides for 12-month offering periods, generally beginning in March and September of each year, and each offering period consists of two six-month purchase periods.

On each purchase date, participating employees will purchase Class A common stock at a price per share equal to 85% of the lesser of the fair market value of our Class A common stock on (i) the first trading day of the applicable offering period or (ii) the last trading day of each purchase period in the applicable offering period. If the stock price of our Class A common stock on any purchase date in an offering period is lower than the stock price on the enrollment date of that offering period, the offering period will immediately reset after the purchase of shares on such purchase date and automatically roll into a new offering period.

During the fiscal year ended July 31, 2022, 2.8 million shares of common stock were purchased under the 2016 ESPP for an aggregate amount of $62.6 million. As of July 31, 2022, 2.4 million shares were available for future issuance under the 2016 ESPP.

We use the Black-Scholes option pricing model to determine the fair value of shares purchased under the 2016 ESPP with the following weighted average assumptions on the date of grant:


	Fiscal Year Ended July 31,
	2020			2021			2022
Expected term (in years)		0.92			0.77			0.81
Risk-free interest rate		0.1	%		0.1	%		1.0	%
Volatility		73.4	%		56.9	%		43.3	%
Dividend yield		—	%		—	%		—	%

Stock-Based Compensation

Total stock-based compensation expense recognized in our consolidated statements of operations is as follows:


	Fiscal Year Ended July 31,
	2020		2021		2022
	(in thousands)
Cost of revenue:
Product	$	5,334	$	6,023	$	7,379
Support, entitlements and other services		22,014		24,460		30,846
Sales and marketing		126,015		122,815		104,592
Research and development		153,252		150,856		143,759
General and administrative		45,383		54,391		56,670
Total stock-based compensation expense	$	351,998	$	358,545	$	343,246

As of July 31, 2022, unrecognized stock-based compensation expense related to outstanding stock awards was approximately $583.4 million and is expected to be recognized over a weighted average period of approximately 2.5 years.

Restructuring Charges

12 Months Ended

Jul. 31, 2022

Restructuring Charges [Abstract]

Restructuring Charges

NOTE 10. RESTRUCTURING CHARGES

In August 2022, we announced a plan to reduce our global headcount by approximately 270 employees, which represents approximately 4% of our total employees, following a review of our business structure and after taking other cost-cutting measures to reduce expenses. The headcount reduction is part of our ongoing efforts to drive towards profitable growth. We estimate that we will recognize pre-tax restructuring charges in the range of approximately $20.0 million to $25.0 million, consisting primarily of one-time severance and other termination benefit costs.

During fiscal 2022, we recognized restructuring charges of $11.2 million, which consisted primarily of severance and other termination benefit costs directly related to this reduction in force. Of the $11.2 million recognized, $0.2 million is included within support, entitlements and other services cost of revenue, $10.3 million is included within sales and marketing expense, $0.6 million is included within research and development expense, and $0.1 million is included within general and administrative expense on our consolidated statement of operations. We expect that the majority of the remaining charges will be recognized during the first quarter of fiscal 2023.

As of July 31, 2022, we had not made any cash payments related to this restructuring and the $11.2 million of restructuring charges accrued is included within accrued compensation and benefits in our consolidated balance sheet.

Net Loss Per Share

12 Months Ended

Jul. 31, 2022

Earnings Per Share [Abstract]

Net Loss Per Share

NOTE 11. NET LOSS PER SHARE

We adopted ASU 2020-06 on August 1, 2021 using the modified retrospective method, applicable to our convertible senior notes outstanding as of adoption. We have not changed any previously disclosed amounts or provided additional disclosures for comparative periods. ASU 2020-06 requires the if-converted method to be applied for all convertible instruments when calculating diluted earnings per share. Under the if-converted method, shares related to our convertible senior notes, to the extent dilutive, are assumed to be converted into common stock at the beginning of the period.

Basic and diluted net loss per share attributable to common stockholders is presented in conformity with the two-class method required for participating securities. Our Convertible Preferred Stock is considered a participating security. Participating securities do not have a contractual obligation to share in our losses. As such, for the periods we incur net losses, there is no impact on the calculated net loss per share attributable to common stockholders in applying the two-class method.

Basic net income (loss) per share is computed using the weighted average number of common shares outstanding during the period. Diluted net income (loss) per share is computed by giving effect to potentially dilutive common stock equivalents outstanding during the period, as their effect would be dilutive. Potentially dilutive common shares include participating securities and shares issuable upon the exercise of stock options, the exercise of common stock warrants, the exercise of convertible preferred stock warrants, the vesting of RSUs and each purchase under the 2016 ESPP, under the if-converted method.

In loss periods, basic net loss per share and diluted net loss per share are the same, as the effect of potential common shares is antidilutive and therefore excluded.

Effective January 3, 2022, all of our then outstanding shares of Class B common stock, par value $0.000025 per share, were automatically converted into the same number of shares of the Company’s Class A common stock, par value $0.000025 per share, pursuant to the terms of our Amended and Restated Certificate of Incorporation. Prior to this conversion, the rights, including the liquidation and dividend rights, of the holders of our Class A and Class B common stock were identical, except with respect to voting. As the liquidation and dividend rights were identical, our undistributed earnings or losses were allocated on a proportionate basis among the holders of both Class A and Class B common stock. As a result, the net income (loss) per share attributed to common stockholders was the same for both Class A and Class B common stock on an individual or combined basis.

The computation of basic and diluted net loss per share attributable to common stockholders is as follows:


	Fiscal Year Ended July 31,
	2020			2021			2022
	(in thousands, except per share data)
Numerator:
Net loss	$	(872,883	)	$	(1,034,260	)	$	(797,538	)
Denominator:
Weighted average shares—basic and diluted		194,719			206,475			220,529
Net loss per share attributable to common stockholders— basic and diluted	$	(4.48	)	$	(5.01	)	$	(3.62	)

The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the fiscal years presented because including them would have been antidilutive are as follows:


	Fiscal Year Ended July 31,
	2020		2021		2022
	(in thousands)
Outstanding stock options and RSUs		30,178		25,042		23,825
Employee stock purchase plan		4,368		2,838		2,511
Common stock issuable upon the conversion of the Notes		—		1,529		39,968
Contingently issuable shares pursuant to acquisitions		506		253		—
Total		35,052		29,662		66,304

Shares that will be issued in connection with our stock awards and shares that will be purchased under the employee stock purchase plan are generally automatically converted into shares of our Class A common stock. Effective as of the January 3, 2022 conversion described above, outstanding options previously denominated in shares of Class B common stock represent the right to acquire the same number of shares of Class A common stock upon exercise. Common stock issuable upon the conversion of convertible debt represents the antidilutive impact of the 2023 Notes, 2026 Notes and 2027 Notes under the if-converted method.

Income Taxes

12 Months Ended

Jul. 31, 2022

Income Tax Disclosure [Abstract]

Income Taxes

NOTE 12. INCOME TAXES

Income Taxes

Loss before provision for income taxes by fiscal year consisted of the following:


	Fiscal Year Ended July 31,
	2020			2021			2022
	(in thousands)
Domestic	$	(905,840	)	$	(1,066,307	)	$	(833,507	)
Foreign		50,619			50,534			55,233
Loss before provision for income taxes	$	(855,221	)	$	(1,015,773	)	$	(778,274	)

Provision for income taxes by fiscal year consisted of the following:


	Fiscal Year Ended July 31,
	2020			2021			2022
	(in thousands)
Current:
U.S. federal	$	175		$	9		$	13
State and local		79			99			77
Foreign		18,033			21,801			21,578
Total current taxes		18,287			21,909			21,668
Deferred:
U.S. federal		80			24			23
State and local		—			—			—
Foreign		(705	)		(3,446	)		(2,427	)
Total deferred taxes		(625	)		(3,422	)		(2,404	)
Provision for income taxes	$	17,662		$	18,487		$	19,264

The income tax provision differs from the amount of income tax determined by applying the applicable U.S. federal statutory income tax rate of 21% to pre-tax loss. The reconciliation of the statutory federal income tax and our effective income tax is as follows:


	Fiscal Year Ended July 31,
	2020			2021			2022
	(in thousands)
U.S. federal income tax at statutory rate	$	(179,514	)	$	(213,391	)	$	(163,438	)
Change in valuation allowance		164,453			171,270			117,292
Non-deductible item on fair value remeasurement of derivative liability		—			56,546			41,589
Stock-based compensation		30,913			4,663			14,462
Effect of foreign operations		12,676			9,851			11,210
Research and development tax credits		(19,210	)		(14,694	)		(9,455	)
Non-deductible expenses		5,393			1,739			6,646
Change in unrecognized tax benefit		1,863			2,631			655
State income taxes		79			99			77
Transfer pricing adjustments		7			—			—
Other		1,002			(227	)		226
Total	$	17,662		$	18,487		$	19,264

During the fiscal years ended July 31, 2020, 2021 and 2022, our provision for income taxes was primarily attributable to foreign tax provisions in certain foreign jurisdictions in which we conduct business.

The temporary differences that give rise to significant portions of deferred tax assets and liabilities are as follows:


	As of July 31,
	2021			2022
	(in thousands)
Deferred tax assets:
Net operating loss carryforward	$	573,944		$	665,757
Tax credit carryforward		164,984			184,376
Deferred revenue		168,417			170,243
Leases		40,011			38,843
Interest expense carryforward		15,492			32,692
Intangible assets		28,557			25,403
Accruals and reserves		21,727			23,045
Stock-based compensation		18,957			17,631
Property and equipment		3,385			4,115
Other assets		26,394			23,412
Total deferred tax assets		1,061,868			1,185,517
Deferred tax liabilities:
Deferred commission expense		(83,054	)		(86,253	)
Leases		(38,368	)		(39,886	)
Convertible notes		(246	)		(38,925	)
Prepaid expenses		(2,013	)		(2,290	)
Property and equipment		(3,681	)		(1,271	)
Acquisition-related		(4,633	)		(1,224	)
Other		(2,764	)		(3,142	)
Total deferred tax liabilities		(134,759	)		(172,991	)
Valuation allowance		(918,689	)		(1,002,546	)
Net deferred tax assets	$	8,420		$	9,980

Management believes that based on available evidence, both positive and negative, it is more likely than not that the U.S. deferred tax assets will not be utilized and as such, a full valuation allowance has been recorded.

The valuation allowance for deferred tax assets was $1.0 billion as of July 31, 2022. The net increase in the total valuation allowance for the fiscal years ended July 31, 2021 and 2022 was $206.6 million and $83.9 million, respectively.

As of July 31, 2022, we had approximately $3.0 billion of federal net operating loss carryforwards and $1.8 billion of state net operating loss carryforwards available to reduce future taxable income, which will begin to expire in fiscal 2023. In addition, we had approximately $124.0 million of federal research credit carryforwards, $96.4 million of state research credit carryforwards and $12.1 million of foreign tax credit carryforwards. The federal credits will begin to expire in fiscal 2030 and the state credits can be carried forward indefinitely. The foreign credits will begin to expire in fiscal 2027.

Utilization of the net operating loss and tax credit carryforwards may be subject to an annual limitation due to the ownership change limitations provided by the Internal Revenue Code of 1986, as amended, and similar state provisions. Any annual limitation may result in the expiration of net operating losses and credits before utilization. If an ownership change occurred, utilization of the net operating loss and tax credit carryforwards could be significantly reduced.

As of July 31, 2022, we held an aggregate of $165.9 million in cash and cash equivalents in our foreign subsidiaries, of which $73.1 million was denominated in U.S. dollars. We attribute net revenue, costs and expenses to domestic and foreign components based on the terms of our agreements with our subsidiaries. We do not provide for federal income taxes on the undistributed earnings of our foreign subsidiaries, as such earnings are to be reinvested offshore indefinitely. The income tax liability would be insignificant if these earnings were to be repatriated.

The income tax benefit and provision for the fiscal year ended July 31, 2022 are based on the assumption that foreign undistributed earnings are indefinitely reinvested. We will continue to evaluate whether or not to continue to assert indefinite reinvestment on part or all of our foreign undistributed earnings. In the event we determine not to continue to assert the permanent reinvestment of part or all of our foreign undistributed earnings, such a determination could result in the accrual and payment of additional foreign, state and local taxes.

The 2017 Tax Cuts and Jobs Act requires research and development expenditures incurred for the tax year beginning after December 31, 2021 to be capitalized and amortized ratably over five years for domestic research and 15 years for international research. The mandatory capitalization requirement should have no material impact on our income tax provision for the fiscal year ended July 31, 2023 due to our tax attributes carryover and full valuation allowance position. On August 16, 2022, President Biden signed the Inflation Reduction Act, which includes a new minimum tax on certain large corporations and an excise tax on stock buybacks. We do not anticipate this legislation to have a material impact on our consolidated financial statements.

We recognize uncertain tax positions in our financial statements if that position will more likely than not be sustained on audit, based on the technical merits of the position. A reconciliation of our unrecognized tax benefits, excluding accrued interest and penalties, is as follows:


	Fiscal Year Ended July 31,
	2021			2022
	(in thousands)
Balance at the beginning of the year	$	85,257		$	89,775
Increases related to current year tax positions		4,335			3,499
Increases related to prior year tax positions		328			604
Decreases related to prior year tax positions		—			(2,263	)
Lapse of statute of limitations/Settlements		(145	)		(942	)
Balance at the end of the year	$	89,775		$	90,673

During the fiscal year ended July 31, 2022, the net increase in unrecognized tax positions was primarily attributable to federal and state research and development credits and intercompany charges.

As of July 31, 2022, if uncertain tax positions are fully recognized in the future, it would result in a $14.4 million impact to our effective tax rate, primarily relating to positions in foreign jurisdictions, and the remaining amount would result in adjustments to deferred tax assets and corresponding adjustments to the valuation allowance.

We recognize interest and/or penalties related to income tax matters as a component of income tax expense. As of July 31, 2022, we had recognized $5.3 million of accrued interest and penalties related to uncertain tax positions.

We file income tax returns in the U.S. federal jurisdiction as well as various U.S. states and foreign jurisdictions. The tax years 2009 and forward remain open to examination by the major jurisdictions in which we are subject to tax. These fiscal years outside the normal statute of limitation remain open to audit by tax authorities due to tax attributes generated in those early years, which have been carried forward and may be audited in subsequent years when utilized. We are subject to the continuous examination of income tax returns by various tax authorities. We regularly assess the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of the provision for income taxes. We believe that adequate amounts have been reserved for any adjustments that may ultimately result from these examinations. We do not anticipate a significant impact to the gross unrecognized tax benefits within the next 12 months related to these years.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 21
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 14
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 270
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI https://asc.fasb.org/topic&trid=2144680

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

Segment Information

12 Months Ended

Jul. 31, 2022

Segment Reporting [Abstract]

Segment Information

NOTE 13. SEGMENT INFORMATION

Our chief operating decision maker is a group which is comprised of our Chief Executive Officer and Chief Financial Officer. This group reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. Accordingly, we have a single reportable segment.

The following table sets forth revenue by geographic location based on bill-to location:


	Fiscal Year Ended July 31,
	2020		2021		2022
	(in thousands)
U.S.	$	706,110	$	758,128	$	887,141
Europe, the Middle East and Africa		277,489		320,837		374,186
Asia Pacific		265,092		260,637		274,373
Other Americas		58,991		54,762		45,096
Total revenue	$	1,307,682	$	1,394,364	$	1,580,796

The following table sets forth long-lived assets, which primarily include property and equipment, net, by geographic location:


	As of July 31,
	2021		2022
	(in thousands)
United States	$	86,468	$	74,472
International		45,153		38,968
Total long-lived assets	$	131,621	$	113,440

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI https://asc.fasb.org/topic&trid=2134510

+ Details

Overview and Summary of Significant Accounting Policies (Policies)

12 Months Ended

Jul. 31, 2022

Accounting Policies [Abstract]

Principles of Consolidation

Use of Estimates

Concentration of Risk

For each significant Partner, revenue as a percentage of total revenue and accounts receivable as a percentage of total accounts receivable, net are as follows:


	Revenue									Accounts Receivable as of
	Fiscal Year Ended July 31,									July 31, 2021			July 31, 2022
Partners	2020			2021			2022
Partner A		29	%		32	%		33	%		35	%		26	%
Partner B		14	%		15	%		15	%		23	%		11	%
Partner C	(1)				10	%		11	%	(1)			(1)

(1)

Less than 10%

Cash, Cash Equivalents and Short-Term Investments

Fair Value Measurement

Convertible Senior Notes

Derivative Liability

Accounts Receivable and Allowance for Credit Losses

The changes in the allowance for credit losses are as follows:


	Fiscal Year Ended July 31,
	2020			2021			2022
	(in thousands)
Allowance for credit losses—beginning balance	$	379		$	804		$	892
Charged to allowance for credit losses		822			655			200
Recoveries		(22	)		(286	)		(80	)
Write-offs		(375	)		(281	)		(368	)
Allowance for credit losses—ending balance	$	804		$	892		$	644

Property and Equipment

Leases

Goodwill, Intangible Assets and Other Long-Lived Assets

There have been no indicators of impairment of goodwill, intangible assets or other long-lived assets and we did not record any material impairment losses during fiscal 2020, 2021 or 2022.

Revenue Recognition

•

Determination of the transaction price — The transaction price is determined based on the consideration to which we will be entitled in exchange for transferring goods or services to the customer.

•

Cost of Revenue

Warranties

Research and Development

Stock-Based Compensation

Recently Adopted Accounting Pronouncements

Overview and Summary of Significant Accounting Policies (Tables)

12 Months Ended

Jul. 31, 2022

Accounting Policies [Abstract]

Schedules of Concentration of Revenue and Accounts Receivable

For each significant Partner, revenue as a percentage of total revenue and accounts receivable as a percentage of total accounts receivable, net are as follows:


	Revenue									Accounts Receivable as of
	Fiscal Year Ended July 31,									July 31, 2021			July 31, 2022
Partners	2020			2021			2022
Partner A		29	%		32	%		33	%		35	%		26	%
Partner B		14	%		15	%		15	%		23	%		11	%
Partner C	(1)				10	%		11	%	(1)			(1)

(1)

Less than 10%

Schedule of Changes in Allowance for Credit Losses

The changes in the allowance for credit losses are as follows:


	Fiscal Year Ended July 31,
	2020			2021			2022
	(in thousands)
Allowance for credit losses—beginning balance	$	379		$	804		$	892
Charged to allowance for credit losses		822			655			200
Recoveries		(22	)		(286	)		(80	)
Write-offs		(375	)		(281	)		(368	)
Allowance for credit losses—ending balance	$	804		$	892		$	644

Revenue, Deferred Revenue and Deferred Commissions (Tables)

12 Months Ended

Jul. 31, 2022

Revenue Recognition and Deferred Revenue [Abstract]

Revenue by Arrangement, Disclosure

The following table depicts the disaggregation of revenue by revenue type, consistent with how we evaluate our financial performance:


	Fiscal Year Ended July 31,
	2020		2021		2022
	(in thousands)
Subscription	$	1,030,180	$	1,243,621	$	1,433,773
Non-portable software		208,158		71,390		49,694
Hardware		23,455		6,259		5,585
Professional services		45,889		73,094		91,744
Total revenue	$	1,307,682	$	1,394,364	$	1,580,796

Deferred Revenue, by Arrangement, Disclosure

Significant changes in the balance of deferred revenue (contract liability) and deferred commissions (contract asset) for the periods presented are as follows:


	Deferred Revenue			Deferred Commissions
	(in thousands)
Balance as of July 31, 2020	$	1,183,441		$	215,528
Additions (1)		1,523,846			310,966
Revenue/commissions recognized		(1,394,364	)		(183,074	)
Balance as of July 31, 2021		1,312,923			343,420
Additions (1)		1,713,411			229,524
Revenue/commissions recognized		(1,580,796	)		(205,354	)
Balance as of July 31, 2022	$	1,445,538		$	367,590

Fair Value Measurements (Tables)

12 Months Ended

Jul. 31, 2022

Fair Value Disclosures [Abstract]

Schedule of Financial Assets and Liabilities Measured on Recurring Basis

The fair value of our financial assets measured on a recurring basis is as follows:


	As of July 31, 2021
	Level I		Level II		Level III		Total
	(in thousands)
Financial Assets:
Cash equivalents:
Money market funds	$	72,583	$	—	$	—	$	72,583
Commercial paper		—		29,997		—		29,997
Corporate bonds		—		2,002		—		2,002
Short-term investments:
Corporate bonds		—		513,688		—		513,688
Commercial paper		—		347,088		—		347,088
U.S. Government securities		—		67,230		—		67,230
Total measured at fair value	$	72,583	$	960,005	$	—	$	1,032,588
Cash								181,141
Total cash, cash equivalents and short-term investments							$	1,213,729


	As of July 31, 2022
	Level I		Level II		Level III		Total
	(in thousands)
Financial Assets:
Cash equivalents:
Money market funds	$	227,796	$	—	$	—	$	227,796
Commercial paper		—		27,927		—		27,927
Short-term investments:
Corporate bonds		—		409,024		—		409,024
Commercial paper		—		317,738		—		317,738
U.S. Government securities		—		194,667		—		194,667
Total measured at fair value	$	227,796	$	949,356	$	—	$	1,177,152
Cash								147,127
Total cash, cash equivalents and short-term investments							$	1,324,279

The carrying values and estimated fair values of financial instruments not recorded at fair value are as follows:


	As of July 31, 2021 (1)				As of July 31, 2022
	Carrying Value		Estimated Fair Value		Carrying Value		Estimated Fair Value
	(in thousands)
2023 Notes	$	523,671	$	602,272	$	145,456	$	143,154
2026 Notes		532,023		1,128,953		589,200		759,086
2027 Notes (2)		—		—		567,005		400,252
Total	$	1,055,694	$	1,731,225	$	1,301,661	$	1,302,492

(1)

(2)

The 2027 Notes were issued in September 2021.

Schedule of Derivative Liabilities at Fair Value


	Three Months Ended October 31, 2021
	(in thousands)
Derivative liability at July 31, 2021	$	500,175
Change in fair value		198,038
Derivative liability at September 15, 2021		698,213
Reclass to equity upon conversion price becoming fixed		(698,213	)
Derivative liability at October 31, 2021	$	—

Fair Value Measurement Inputs and Valuation Techniques

We estimated the fair value of the derivative liability using a binomial model, with the following valuation inputs:


	As of
	July 31, 2021	September 15, 2021
Conversion ratio (1)	Conversion price of $27.75 with a 36.036 conversion rate per $1,000	Conversion price of $27.75 with a 36.036 conversion rate per $1,000
Risk-free rate	0.7%	0.8%
Discount rate (2)	6.5%	6.5%
Volatility	40.0%	45.0%
Stock price	$36.02	$42.77

(1)

The conversion ratio was calculated based on the achievement of the associated financial performance metric.

(2)

The discount rate was estimated based on the implied rate for the 2023 Notes as well as a credit analysis.

Balance Sheet Components (Tables)

12 Months Ended

Jul. 31, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Investments in Marketable Debt Securities, by Contractual Maturity Date

The following table summarizes the estimated fair value of our investments in marketable debt securities by their contractual maturity dates:


	As of July 31, 2022
	(in thousands)
Due within one year	$	770,454
Due in one to two years		150,975
Total	$	921,429

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consists of the following:


	As of July 31,
	2021		2022
	(in thousands)
Prepaid operating expenses	$	36,455	$	48,842
VAT receivables		8,290		7,514
Other current assets		12,071		37,431
Total prepaid expenses and other current assets	$	56,816	$	93,787

Schedule of Property and Equipment, Net

Property and equipment, net consists of the following:


	Estimated	As of July 31,
	Useful Life	2021			2022
	(in months)	(in thousands)
Computer, production, engineering and other equipment	36	$	300,583		$	341,536
Demonstration units	12		68,992			61,914
Leasehold improvements	(1)		62,676			61,443
Furniture and fixtures	60		16,518			16,508
Total property and equipment, gross			448,769			481,401
Less: accumulated depreciation (2)			(317,148	)		(367,961	)
Total property and equipment, net		$	131,621		$	113,440

(1)

Leasehold improvements are amortized over the shorter of the estimated useful lives of the improvements or the remaining lease term.

(2)

Schedule of Finite-Lived Intangible Assets

Intangible assets, net consists of the following:


	As of July 31,
	2021			2022
	(in thousands)
Developed technology	$	79,300		$	79,300
Customer relationships		8,860			8,860
Trade name		4,170			4,170
Total intangible assets, gross		92,330			92,330
Less:
Accumulated amortization of developed technology		(50,764	)		(64,344	)
Accumulated amortization of customer relationships		(6,513	)		(8,074	)
Accumulated amortization of trade name		(3,041	)		(4,083	)
Total accumulated amortization		(60,318	)		(76,501	)
Total intangible assets, net	$	32,012		$	15,829

The changes in the net book value of intangible assets, net are as follows:


	As of July 31,
	2021			2022
	(in thousands)
Intangible assets, net—beginning balance	$	49,392		$	32,012
Amortization of intangible assets (1)		(17,380	)		(16,183	)
Intangible assets, net—ending balance	$	32,012		$	15,829

(1)

Represents amortization expense related to intangible assets recognized during the year in our consolidated statements of operations, within product cost of revenue and sales and marketing expense.

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense

The estimated future amortization expense of our intangible assets is as follows:


Fiscal Year Ending July 31:	Amount
	(in thousands)
2023	$	10,856
2024		3,210
2025		1,763
Total	$	15,829

Schedule of Accrued Liabilities

Accrued Compensation and Benefits

Accrued compensation and benefits consists of the following:


	As of July 31,
	2021		2022
	(in thousands)
Accrued commissions	$	48,321	$	32,886
Accrued vacation		26,961		23,140
Payroll taxes payable		21,603		21,060
Accrued wages and taxes		1,675		20,807
Contributions to ESPP withheld		26,735		19,174
Accrued benefits		10,243		11,774
Accrued bonus		14,878		9,782
Other		11,921		11,188
Total accrued compensation and benefits	$	162,337	$	149,811

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consists of the following:


	As of July 31,
	2021		2022
	(in thousands)
Income taxes payable	$	13,309	$	13,206
Accrued professional services		3,541		5,499
Other		22,554		30,527
Total accrued expenses and other current liabilities	$	39,404	$	49,232

Convertible Senior Notes (Tables)

12 Months Ended

Jul. 31, 2022

Debt Instrument [Line Items]

Net Proceeds from Notes

The total net proceeds from the issuance of the 2023 Notes were as follows:


	Amount
	(in thousands)
Principal amount	$	575,000
Less: initial purchasers' discount		(10,781	)
Less: cost of the bond hedges		(143,175	)
Add: proceeds from the sale of warrants		87,975
Less: other issuance costs		(707	)
Net proceeds	$	508,312

2023 Convertible Senior Notes

Debt Instrument [Line Items]

Components of Notes

The 2023 Notes consisted of the following:


	As of July 31,
	2021			2022
	(in thousands)
Principal amounts:
Principal	$	575,000		$	145,704
Unamortized debt discount (1)		(48,616	)		—
Unamortized debt issuance costs (1)		(2,713	)		(248	)
Net carrying amount	$	523,671		$	145,456
Carrying amount of equity component (2)	$	148,598		$	—

(1)

(2)

Included in our consolidated balance sheets as of July 31, 2021 within additional paid-in capital, net of $3.0 million in equity issuance costs.

Interest Expense Recognized

The following table sets forth the total interest expense recognized related to the 2023 Notes:


	Fiscal Year Ended July 31,
	2020		2021		2022
	(in thousands)
Interest expense related to amortization of debt discount	$	29,658	$	31,682	$	—
Interest expense related to amortization of debt issuance costs		1,654		1,767		844
Total interest expense	$	31,312	$	33,449	$	844

2026 Convertible Senior Notes

Debt Instrument [Line Items]

Components of Notes

The 2026 Notes consisted of the following:


	As of July 31,
	2021			2022
	(in thousands)
Principal amounts:
Principal	$	750,000		$	750,000
Non-cash interest expense converted to principal		8,906			27,997
Unamortized debt discount (conversion feature) (1)		(203,619	)		(169,438	)
Unamortized debt issuance costs (1)		(23,264	)		(19,359	)
Net carrying amount	$	532,023		$	589,200

(1)

Interest Expense Recognized

The following table sets forth the total interest expense recognized related to the 2026 Notes:


	Fiscal Year Ended July 31,
	2021		2022
	(in thousands)
Interest expense related to amortization of debt discount	$	27,291	$	34,180
Interest expense related to amortization of debt issuance costs		3,119		3,906
Non-cash interest expense		16,074		19,270
Total interest expense	$	46,484	$	57,356

2027 Convertible Senior Notes

Debt Instrument [Line Items]

Components of Notes

The 2027 Notes consisted of the following:


	As of July 31, 2022
	(in thousands)
Principal amounts:
Principal	$	575,000
Unamortized debt issuance costs (1)		(7,995	)
Net carrying amount	$	567,005

(1)

Interest Expense Recognized

The following table sets forth the total interest expense recognized related to the 2027 Notes:


	Fiscal Year Ended July 31,
	2022
	(in thousands)
Contractual interest expense	$	1,229
Interest expense related to amortization of debt issuance costs		1,302
Total interest expense	$	2,531

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 55
-Paragraph 69B
-URI https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 55
-Paragraph 69E
-URI https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644

+ Details

Leases (Tables)

12 Months Ended

Jul. 31, 2022

Leases [Abstract]

Assets and Liabilities, Lessee

Supplemental balance sheet information related to leases is as follows:


	As of July 31,
	2021			2022
	(in thousands)
Operating leases:
Operating lease right-of-use assets, gross	$	170,277		$	188,060
Accumulated amortization		(64,374	)		(69,320	)
Operating lease right-of-use assets, net	$	105,903		$	118,740
Operating lease liabilities—current	$	42,670		$	39,801
Operating lease liabilities—non-current		86,599			89,782
Total operating lease liabilities	$	129,269		$	129,583
Weighted average remaining lease term (in years):		3.1			5.1
Weighted average discount rate:		5.5	%		5.7	%


	As of July 31,
	2021			2022
	(in thousands)
Finance leases:
Finance lease right-of-use assets, gross (1)	$	8,972		$	13,501
Accumulated amortization (1)		(687	)		(3,053	)
Finance lease right-of-use assets, net (1)	$	8,285		$	10,448
Finance lease liabilities—current (2)	$	1,772		$	2,685
Finance lease liabilities—non-current (3)		6,527			7,806
Total finance lease liabilities	$	8,299		$	10,491
Weighted average remaining lease term (in years):		4.7			3.9
Weighted average discount rate:		6.7	%		5.9	%

(1)

Included in our consolidated balance sheets within property and equipment, net.

(2)

Included in our consolidated balance sheets within accrued expenses and other current liabilities.

(3)

Included in our consolidated balance sheets within other liabilities—non-current.

Supplemental Cash Flow and Other Information Related to Leases

Supplemental cash flow and other information related to leases is as follows:


	Fiscal Year Ended July 31,
	2021		2022
	(in thousands)
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	46,216	$	48,509
Financing cash flows from finance leases	$	459	$	1,089
Lease liabilities arising from obtaining right-of-use assets:
Operating leases	$	16,174	$	55,797
Finance leases	$	9,622	$	4,529

Lessee Operating and Finance Lease, Liability, Maturity

The undiscounted cash flows for our lease liabilities as of July 31, 2022 were as follows:


Fiscal Year Ending July 31:	Operating Leases			Finance Leases			Total
	(in thousands)
2023	$	43,199		$	2,750		$	45,949
2024		30,393			2,750			33,143
2025		17,100			2,750			19,850
2026		13,805			2,048			15,853
2027		12,699			337			13,036
Thereafter		36,396			—			36,396
Total lease payments		153,592			10,635			164,227
Less: imputed interest		(24,009	)		(144	)		(24,153	)
Total lease obligation		129,583			10,491			140,074
Less: current lease obligations		(39,801	)		(2,685	)		(42,486	)
Long-term lease obligations	$	89,782		$	7,806		$	97,588

Stockholders' Equity (Tables)

12 Months Ended

Jul. 31, 2022

Equity [Abstract]

Schedule of Stock by Class

As of July 31, 2022, we had reserved shares of common stock for future issuance as follows:


	As of July 31, 2022
	(in thousands)
Shares reserved for future equity grants		15,159
Shares underlying outstanding stock options		1,689
Shares underlying outstanding restricted stock units		22,136
Shares reserved for future employee stock purchase plan awards		2,362
Total		41,346

- Definition

Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 45
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(27))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644

+ Details

Equity Incentive Plans (Tables)

12 Months Ended

Jul. 31, 2022

Share-Based Payment Arrangement [Abstract]

Schedule of RSUs Activity

Below is a summary of RSU activity, including MSUs, under the Stock Plans:


	Fiscal Year Ended July 31,
	2021					2022
	Number of Shares			Weighted Average Grant Date Fair Value per Share		Number of Shares			Weighted Average Grant Date Fair Value per Share
	(in thousands)
Outstanding at beginning of period		22,632		$	32.70		21,708		$	30.98
Granted		13,732		$	29.60		15,575		$	30.92
Released		(9,744	)	$	32.58		(9,626	)	$	32.68
Forfeited		(4,912	)	$	31.87		(5,521	)	$	32.55
Outstanding at end of period		21,708		$	30.98		22,136		$	29.81

Schedule of Stock Option Activity

Below is a summary of stock option activity under the Stock Plans:


	Fiscal Year Ended July 31,
	2021									2022
	Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life		Aggregate Intrinsic Value		Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life		Aggregate Intrinsic Value
	(in thousands)					(in years)		(in thousands)		(in thousands)					(in years)		(in thousands)
Outstanding at beginning of period		7,546		$	5.10		3.6	$	129,010		3,334		$	5.20		2.8	$	102,740
Options granted		—		$	—						—		$	—
Options exercised		(3,712	)	$	4.07						(1,643	)	$	3.94
Options canceled/forfeited		(500	)	$	12.00						(2	)	$	13.04
Outstanding at end of period		3,334		$	5.20		2.8	$	102,740		1,689		$	6.43		1.9	$	14,707
Exercisable at end of period		3,334		$	5.20		2.8	$	102,739		1,689		$	6.43		1.9	$	14,707

Schedule of ESPP Valuation Assumptions

We use the Black-Scholes option pricing model to determine the fair value of shares purchased under the 2016 ESPP with the following weighted average assumptions on the date of grant:


	Fiscal Year Ended July 31,
	2020			2021			2022
Expected term (in years)		0.92			0.77			0.81
Risk-free interest rate		0.1	%		0.1	%		1.0	%
Volatility		73.4	%		56.9	%		43.3	%
Dividend yield		—	%		—	%		—	%

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs

Total stock-based compensation expense recognized in our consolidated statements of operations is as follows:


	Fiscal Year Ended July 31,
	2020		2021		2022
	(in thousands)
Cost of revenue:
Product	$	5,334	$	6,023	$	7,379
Support, entitlements and other services		22,014		24,460		30,846
Sales and marketing		126,015		122,815		104,592
Research and development		153,252		150,856		143,759
General and administrative		45,383		54,391		56,670
Total stock-based compensation expense	$	351,998	$	358,545	$	343,246

Net Loss Per Share (Tables)

12 Months Ended

Jul. 31, 2022

Earnings Per Share [Abstract]

Schedule of Basic and Diluted Net Loss Per Share

The computation of basic and diluted net loss per share attributable to common stockholders is as follows:


	Fiscal Year Ended July 31,
	2020			2021			2022
	(in thousands, except per share data)
Numerator:
Net loss	$	(872,883	)	$	(1,034,260	)	$	(797,538	)
Denominator:
Weighted average shares—basic and diluted		194,719			206,475			220,529
Net loss per share attributable to common stockholders— basic and diluted	$	(4.48	)	$	(5.01	)	$	(3.62	)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share


	Fiscal Year Ended July 31,
	2020		2021		2022
	(in thousands)
Outstanding stock options and RSUs		30,178		25,042		23,825
Employee stock purchase plan		4,368		2,838		2,511
Common stock issuable upon the conversion of the Notes		—		1,529		39,968
Contingently issuable shares pursuant to acquisitions		506		253		—
Total		35,052		29,662		66,304

Income Taxes (Tables)

12 Months Ended

Jul. 31, 2022

Income Tax Disclosure [Abstract]

Schedule of Income before Income Tax, Domestic and Foreign

Loss before provision for income taxes by fiscal year consisted of the following:


	Fiscal Year Ended July 31,
	2020			2021			2022
	(in thousands)
Domestic	$	(905,840	)	$	(1,066,307	)	$	(833,507	)
Foreign		50,619			50,534			55,233
Loss before provision for income taxes	$	(855,221	)	$	(1,015,773	)	$	(778,274	)

Schedule of Components of Income Tax Expense (Benefit)

Provision for income taxes by fiscal year consisted of the following:


	Fiscal Year Ended July 31,
	2020			2021			2022
	(in thousands)
Current:
U.S. federal	$	175		$	9		$	13
State and local		79			99			77
Foreign		18,033			21,801			21,578
Total current taxes		18,287			21,909			21,668
Deferred:
U.S. federal		80			24			23
State and local		—			—			—
Foreign		(705	)		(3,446	)		(2,427	)
Total deferred taxes		(625	)		(3,422	)		(2,404	)
Provision for income taxes	$	17,662		$	18,487		$	19,264

Schedule of Effective Income Tax Rate Reconciliation


	Fiscal Year Ended July 31,
	2020			2021			2022
	(in thousands)
U.S. federal income tax at statutory rate	$	(179,514	)	$	(213,391	)	$	(163,438	)
Change in valuation allowance		164,453			171,270			117,292
Non-deductible item on fair value remeasurement of derivative liability		—			56,546			41,589
Stock-based compensation		30,913			4,663			14,462
Effect of foreign operations		12,676			9,851			11,210
Research and development tax credits		(19,210	)		(14,694	)		(9,455	)
Non-deductible expenses		5,393			1,739			6,646
Change in unrecognized tax benefit		1,863			2,631			655
State income taxes		79			99			77
Transfer pricing adjustments		7			—			—
Other		1,002			(227	)		226
Total	$	17,662		$	18,487		$	19,264

Schedule of Deferred Tax Assets and Liabilities

The temporary differences that give rise to significant portions of deferred tax assets and liabilities are as follows:


	As of July 31,
	2021			2022
	(in thousands)
Deferred tax assets:
Net operating loss carryforward	$	573,944		$	665,757
Tax credit carryforward		164,984			184,376
Deferred revenue		168,417			170,243
Leases		40,011			38,843
Interest expense carryforward		15,492			32,692
Intangible assets		28,557			25,403
Accruals and reserves		21,727			23,045
Stock-based compensation		18,957			17,631
Property and equipment		3,385			4,115
Other assets		26,394			23,412
Total deferred tax assets		1,061,868			1,185,517
Deferred tax liabilities:
Deferred commission expense		(83,054	)		(86,253	)
Leases		(38,368	)		(39,886	)
Convertible notes		(246	)		(38,925	)
Prepaid expenses		(2,013	)		(2,290	)
Property and equipment		(3,681	)		(1,271	)
Acquisition-related		(4,633	)		(1,224	)
Other		(2,764	)		(3,142	)
Total deferred tax liabilities		(134,759	)		(172,991	)
Valuation allowance		(918,689	)		(1,002,546	)
Net deferred tax assets	$	8,420		$	9,980

Schedule of Unrecognized Tax Benefits Roll Forward

A reconciliation of our unrecognized tax benefits, excluding accrued interest and penalties, is as follows:


	Fiscal Year Ended July 31,
	2021			2022
	(in thousands)
Balance at the beginning of the year	$	85,257		$	89,775
Increases related to current year tax positions		4,335			3,499
Increases related to prior year tax positions		328			604
Decreases related to prior year tax positions		—			(2,263	)
Lapse of statute of limitations/Settlements		(145	)		(942	)
Balance at the end of the year	$	89,775		$	90,673

Segment Information (Tables)

12 Months Ended

Jul. 31, 2022

Segment Reporting [Abstract]

Schedule of Revenue by Geographic Area

The following table sets forth revenue by geographic location based on bill-to location:


	Fiscal Year Ended July 31,
	2020		2021		2022
	(in thousands)
U.S.	$	706,110	$	758,128	$	887,141
Europe, the Middle East and Africa		277,489		320,837		374,186
Asia Pacific		265,092		260,637		274,373
Other Americas		58,991		54,762		45,096
Total revenue	$	1,307,682	$	1,394,364	$	1,580,796

Schedule of Long-lived Assets by Geographical Location

The following table sets forth long-lived assets, which primarily include property and equipment, net, by geographic location:


	As of July 31,
	2021		2022
	(in thousands)
United States	$	86,468	$	74,472
International		45,153		38,968
Total long-lived assets	$	131,621	$	113,440

Overview and Summary of Significant Accounting Policies - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands		12 Months Ended
	Aug. 01, 2021	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2020	Sep. 30, 2021	Sep. 24, 2020	Jan. 31, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Impairment losses		$ 0	$ 0	$ 0
Foreign currency transaction gain (loss), before tax		(3,200)	(8,900)	(9,400)
Advertising expense		13,700	22,100	$ 38,700
Accumulated deficit	$ 100,600	$ 4,368,026	$ 3,627,355
Adjustments to Additional Paid in Capital, Other	148,600
Partner [Member] \| Revenue Benchmark [Member] \| Customer Concentration Risk [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Interest rate, stated percentage		10.00%	10.00%	10.00%
2023 Convertible Senior Notes \| Convertible Debt
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Closing trading price		$ 100
Interest rate, stated percentage		0.00%					0.00%
2026 Convertible Senior Notes \| Convertible Debt
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Interest rate, stated percentage		2.50%				2.50%
2027 Convertible Senior Notes
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Interest rate, stated percentage		0.25%
2027 Convertible Senior Notes \| Convertible Debt
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Closing trading price		$ 100
Interest rate, stated percentage		0.25%			0.25%
Convertible Notes Payable [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Increase in carrying value of the notes outstanding	$ 48,000
ASU 2020-06
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Change in accounting principle, accounting standards update, adopted		true
Change in accounting principle, accounting standards update, adoption date		Aug. 01, 2021
Change in accounting principle, accounting standards update, immaterial effect		true	false
Hardware
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Product warranty duration		1 year
Product warranty replacement period (in years)		3 years
Software
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Product warranty duration		90 days

Overview and Summary of Significant Accounting Policies - Schedules of Concentration of Revenue and Accounts Receivable (Details) - Partner Concentration Risk	12 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2020
Revenue [Member] \| Partner A
Concentration Risk [Line Items]
Concentration risk percentage	33.00%	32.00%	29.00%
Revenue [Member] \| Partner B
Concentration Risk [Line Items]
Concentration risk percentage	15.00%	15.00%	14.00%
Revenue [Member] \| Partner C
Concentration Risk [Line Items]
Concentration risk percentage	11.00%	10.00%
Accounts Receivable \| Partner A
Concentration Risk [Line Items]
Concentration risk percentage	26.00%	35.00%
Accounts Receivable \| Partner B
Concentration Risk [Line Items]
Concentration risk percentage	11.00%	23.00%

Overview and Summary of Significant Accounting Policies - Schedule of Changes in Allowance for Credit Losses (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2020
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Allowance for credit losses-beginning balance	$ 892	$ 804	$ 379
Charged to allowance for credit losses	200	655	822
Recoveries	(80)	(286)	(22)
Write-offs	(368)	(281)	(375)
Allowance for credit losses-ending balance	$ 644	$ 892	$ 804

Business Combinations - Preliminary Aggregate Purchase Price Allocation (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jul. 31, 2021
Business Acquisition [Line Items]
Goodwill	$ 185,260	$ 185,260

- Definition

Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.

+ References + Details

Revenue, Deferred Revenue and Deferred Commissions - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2020
Total revenue	$ 1,580,796	$ 1,394,364	$ 1,307,682
Amount deferred in prior period	$ 592,600	488,200
Percent expected to be recognized in next year	54.00%
Contracted revenue not recognized	$ 1,600,000
Ratable
Total revenue	770,400	639,300	508,800
Upfront
Total revenue	$ 663,400	$ 604,300	$ 521,300
Minimum
Software, license term	1 year
Maximum
Software, license term	5 years

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

+ Details

Revenue, Deferred Revenue and Deferred Commissions - Revenue by Arrangement, Disclosure (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2020
Condensed Income Statements, Captions [Line Items]
Total revenue	$ 1,580,796	$ 1,394,364	$ 1,307,682
Subscription
Condensed Income Statements, Captions [Line Items]
Total revenue	1,433,773	1,243,621	1,030,180
Non-portable software
Condensed Income Statements, Captions [Line Items]
Total revenue	49,694	71,390	208,158
Hardware
Condensed Income Statements, Captions [Line Items]
Total revenue	5,585	6,259	23,455
Professional services
Condensed Income Statements, Captions [Line Items]
Total revenue	$ 91,744	$ 73,094	$ 45,889

- Definition

+ References

+ Details

Revenue, Deferred Revenue and Deferred Commissions - Deferred Revenue, by Arrangement, Disclosure (Details) - USD ($)
$ in Thousands

12 Months Ended

Jul. 31, 2022

Jul. 31, 2021

Movementin Deferred Commissions Roll Forward

Deferred commissions, beginning balance

$ 343,420

$ 215,528

Additions

^[1]

229,524

310,966

Revenue/commissions recognized

(205,354)

(183,074)

Deferred commissions, ending balance

367,590

343,420

Deferred revenue, beginning balance

1,312,923

1,183,441

Additions

^[1]

1,713,411

1,523,846

Revenue/commissions recognized

(1,580,796)

(1,394,364)

Deferred revenue, ending balance

$ 1,445,538

$ 1,312,923

[1]	Includes both billed and unbilled amounts.

Fair Value Measurements - Fair Value of Financial Assets and Liabilities (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jul. 31, 2021
Financial Assets:
Short-term investments:	$ 921,429	$ 928,006
Recurring
Financial Assets:
Total measured at fair value	1,177,152	1,032,588
Cash	147,127	181,141
Total cash, cash equivalents and short-term investments	1,324,279	1,213,729
Recurring \| U.S. Government securities
Financial Assets:
Short-term investments:	194,667	67,230
Recurring \| Corporate bonds
Financial Assets:
Cash equivalents:		2,002
Short-term investments:	409,024	513,688
Recurring \| Commercial paper
Financial Assets:
Cash equivalents:	27,927	29,997
Short-term investments:	317,738	347,088
Recurring \| Money market funds
Financial Assets:
Cash equivalents:	227,796	72,583
Recurring \| Level I
Financial Assets:
Total measured at fair value	227,796	72,583
Recurring \| Level I \| U.S. Government securities
Financial Assets:
Short-term investments:	0	0
Recurring \| Level I \| Corporate bonds
Financial Assets:
Cash equivalents:		0
Short-term investments:	0	0
Recurring \| Level I \| Commercial paper
Financial Assets:
Cash equivalents:	0	0
Short-term investments:	0	0
Recurring \| Level I \| Money market funds
Financial Assets:
Cash equivalents:	227,796	72,583
Recurring \| Level II
Financial Assets:
Total measured at fair value	949,356	960,005
Recurring \| Level II \| U.S. Government securities
Financial Assets:
Short-term investments:	194,667	67,230
Recurring \| Level II \| Corporate bonds
Financial Assets:
Cash equivalents:		2,002
Short-term investments:	409,024	513,688
Recurring \| Level II \| Commercial paper
Financial Assets:
Cash equivalents:	27,927	29,997
Short-term investments:	317,738	347,088
Recurring \| Level II \| Money market funds
Financial Assets:
Cash equivalents:	0	0
Recurring \| Level III
Financial Assets:
Total measured at fair value	0	0
Recurring \| Level III \| U.S. Government securities
Financial Assets:
Short-term investments:	0	0
Recurring \| Level III \| Corporate bonds
Financial Assets:
Cash equivalents:		0
Short-term investments:	0	0
Recurring \| Level III \| Commercial paper
Financial Assets:
Cash equivalents:	0	0
Short-term investments:	0	0
Recurring \| Level III \| Money market funds
Financial Assets:
Cash equivalents:	$ 0	$ 0

Fair Value Measurements - Non-recurring Basis (Details) - Fair Value, Measurements, Nonrecurring - Convertible Debt - USD ($)
$ in Thousands

Jul. 31, 2022

Jul. 31, 2021

^[1]

Reported Value Measurement

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Convertible senior note, fair value disclosure

$ 1,301,661

$ 1,055,694

Reported Value Measurement | 2023 Convertible Senior Notes

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Convertible senior note, fair value disclosure

145,456

523,671

Reported Value Measurement | 2026 Convertible Senior Notes

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Convertible senior note, fair value disclosure

589,200

532,023

Reported Value Measurement | 2027 Convertible Senior Notes

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Convertible senior note, fair value disclosure

^[2]

567,005

Estimate of Fair Value Measurement

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Convertible senior note, fair value disclosure

1,302,492

1,731,225

Estimate of Fair Value Measurement | 2023 Convertible Senior Notes

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Convertible senior note, fair value disclosure

143,154

602,272

Estimate of Fair Value Measurement | 2026 Convertible Senior Notes

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Convertible senior note, fair value disclosure

759,086

1,128,953

Estimate of Fair Value Measurement | 2027 Convertible Senior Notes

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Convertible senior note, fair value disclosure

^[2]

$ 400,252

$ 0

[1]	Prior period amounts have not been adjusted due to our adoption of ASU 2020-06 under the modified retrospective method. For additional information on our adoption of ASU 2020-06, refer to Note 1 and Note 5.
[2]	The 2027 Notes were issued in September 2021.

Fair Value Measurements - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands

12 Months Ended

Jul. 31, 2022

Sep. 15, 2021

Jul. 31, 2021

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Derivative Liability, Fair Value, Gross Liability, Total

$ 698,200

2023 Convertible Senior Notes | Convertible Debt

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Unamortized discount

^[1]

$ 0

$ 48,616

Unamortized debt issuance cost

^[1]

$ 248

2,713

Closing trading price

$ 100

2026 Convertible Senior Notes | Convertible Debt

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Unamortized discount

^[2]

$ 169,438

203,619

Unamortized debt issuance cost

^[2]

19,359

23,264

Non Cash Interest Expense Converted To Principal

27,997

$ 8,906

2027 Convertible Senior Notes | Convertible Debt

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Unamortized debt issuance cost

^[3]

$ 7,995

Closing trading price

$ 100

[1]	Included in our consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2023 Notes using the effective interest rate method. As of July 31, 2021, the effective interest rate was 6.62%. As of July 31, 2022, the effective interest rate was 0.41%.
[2]	Included in our consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2026 Notes using the effective interest rate method. The effective interest rate is 7.05%
[3]	Included in our consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2027 Notes using the effective interest rate method. The effective interest rate is 0.52%.

Fair Value Measurements - Schedule of Changes in Derivative Liability (Details) - USD ($) $ in Thousands	2 Months Ended		12 Months Ended
	Oct. 31, 2021	Sep. 15, 2021	Jul. 31, 2022	Jul. 31, 2021
Fair Value Disclosures [Abstract]
Derivative liability, beginning of period	$ 698,213	$ 500,175	$ 500,175
Change in fair value		198,038	198,038	$ 269,265
Reclass to equity upon conversion price becoming fixed	(698,213)
Derivative liability, end of period	$ 0	$ 698,213	$ 0	$ 500,175

Fair Value Measurements - Schedule of Derivative Liability Measurement Inputs and Valuation Techniques (Details)

Sep. 15, 2021

USD ($)

Jul. 31, 2021

USD ($)

Conversion Price

Fair Value Measurement Inputs and Valuation Techniques [Line Items]

Derivative liability, measurement input

^[1]

27.75

Conversion Ratio

Fair Value Measurement Inputs and Valuation Techniques [Line Items]

Derivative liability, measurement input

^[1]

36.036

Risk Free Interest Rate

Fair Value Measurement Inputs and Valuation Techniques [Line Items]

Derivative liability, measurement input

0.8

0.7

Discount Rate

Fair Value Measurement Inputs and Valuation Techniques [Line Items]

Derivative liability, measurement input

^[2]

6.5

Volatility

Fair Value Measurement Inputs and Valuation Techniques [Line Items]

Derivative liability, measurement input

45.0

40.0

Stock Price

Fair Value Measurement Inputs and Valuation Techniques [Line Items]

Derivative liability, measurement input

42.77

36.02

[1]	The conversion ratio was calculated based on the achievement of the associated financial performance metric.
[2]	The discount rate was estimated based on the implied rate for the 2023 Notes as well as a credit analysis.

Balance Sheet Components - Schedule of Investments in Marketable Debt Securities, by Contractual Maturity Date (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jul. 31, 2021
Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract]
Due within one year	$ 770,454
Due in one to two years	150,975
Total	$ 921,429	$ 928,006

Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jul. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Prepaid operating expenses	$ 48,842	$ 36,455
VAT receivables	7,514	8,290
Other current assets	37,431	12,071
Total prepaid expenses and other current assets	$ 93,787	$ 56,816

Balance Sheet Components - Schedule of Property and Equipment, Net (Details) - USD ($)
$ in Thousands

12 Months Ended

Jul. 31, 2022

Jul. 31, 2021

Property, Plant and Equipment [Line Items]

Total property and equipment, gross

$ 481,401

$ 448,769

Less: accumulated depreciation

^[1]

(367,961)

(317,148)

Total property and equipment, net

$ 113,440

131,621

Computer, production, engineering and other equipment

Property, Plant and Equipment [Line Items]

Estimated Useful Life

36 months

Total property and equipment, gross

$ 341,536

300,583

Demonstration units

Property, Plant and Equipment [Line Items]

Estimated Useful Life

12 months

Total property and equipment, gross

$ 61,914

68,992

Leasehold improvements

Property, Plant and Equipment [Line Items]

Total property and equipment, gross

^[2]

$ 61,443

62,676

Furniture and fixtures

Property, Plant and Equipment [Line Items]

Estimated Useful Life

60 months

Total property and equipment, gross

$ 16,508

$ 16,518

[1]	Includes a $0.9 million write-off related to the impairment of certain leasehold improvements during the fiscal year ended July 31, 2021. For additional information on this lease-related impairment, refer to Note 6.
[2]	Leasehold improvements are amortized over the shorter of the estimated useful lives of the improvements or the remaining lease term.

Balance Sheet Components - Schedule of Property and Equipment, Net (Parenthetical) (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Impairment of Leasehold	$ 0.9	$ 1.2

Balance Sheet Components (Additional Information) (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2020
Property, Plant and Equipment [Member]
Property, Plant and Equipment [Line Items]
Depreciation	$ 69.3	$ 76.5	$ 76.4

Balance Sheet Components - Schedule of Intangible Assets, Net (Details) - USD ($)
$ in Thousands

12 Months Ended

Jul. 31, 2022

Jul. 31, 2021

Finite-lived intangible assets:

Total intangible assets, gross

$ 92,330

Less:

Accumulated amortization

(76,501)

(60,318)

Intangible assets, net

15,829

32,012

Intangible assets, net—beginning balance

32,012

49,392

Amortization of intangible assets

^[1]

(16,183)

(17,380)

Intangible assets, net—ending balance

15,829

32,012

Developed technology

Finite-lived intangible assets:

Finite-lived intangible assets, gross

79,300

Less:

Accumulated amortization

(64,344)

(50,764)

Customer relationships

Finite-lived intangible assets:

Finite-lived intangible assets, gross

8,860

Less:

Accumulated amortization

(8,074)

(6,513)

Trade Names

Finite-lived intangible assets:

Finite-lived intangible assets, gross

4,170

Less:

Accumulated amortization

$ (4,083)

$ (3,041)

[1]	Represents amortization expense related to intangible assets recognized during the year in our consolidated statements of operations, within product cost of revenue and sales and marketing expense.

Balance Sheet Components - Schedule of Finite-lived Intangible Assets, Future Amortization Expense (Details) $ in Thousands	Jul. 31, 2022 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2023	$ 10,856
2024	3,210
2025	1,763
Total	$ 15,829

Balance Sheet Components - Schedule of Changes in the Carrying Amount of Goodwill (Details) $ in Thousands	Jul. 31, 2022 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Beginning Balance	$ 185,260
Ending Balance	$ 185,260

- Definition

+ References + Details

Balance Sheet Components - Schedule of Accrued Compensation Benefits (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jul. 31, 2021
Employee-related Liabilities, Current [Abstract]
Accrued commissions	$ 32,886	$ 48,321
Accrued vacation	23,140	26,961
Payroll taxes payable	21,060	21,603
Accrued wages and taxes	20,807	1,675
Accrued benefits	11,774	10,243
Contributions to ESPP withheld	19,174	26,735
Accrued bonus	9,782	14,878
Other	11,188	11,921
Total accrued compensation and benefits	$ 149,811	$ 162,337

Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jul. 31, 2021
Other Liabilities Disclosure [Abstract]
Income taxes payable	$ 13,206	$ 13,309
Accrued professional services	5,499	3,541
Other	30,527	22,554
Total accrued expenses and other current liabilities	$ 49,232	$ 39,404

Convertible Senior Notes - Additional Information (Details) $ / shares in Units, $ in Thousands, shares in Millions			1 Months Ended		12 Months Ended
	Sep. 30, 2020 USD ($)	Sep. 24, 2020 USD ($) d $ / shares	Sep. 30, 2021 USD ($) PurchasePeriod $ / shares shares	Jan. 31, 2018 USD ($) PurchasePeriod d $ / shares shares	Jul. 31, 2022 USD ($) d $ / shares shares	Jul. 31, 2021 USD ($)	Oct. 31, 2021 USD ($)	Sep. 22, 2021 USD ($)	Sep. 15, 2021 USD ($)
Debt Instrument [Line Items]
Proceeds from Hedge, Financing Activities					$ 39,880
Payments for unwinding of warrants					18,390
Loss on debt extinguishment					(64,910)
Proceeds from the issuance of convertible notes, net of issuance costs					88,687	$ 723,617
Derivative liability					0	500,175	$ 0		$ 698,213
2023 Convertible Senior Notes
Debt Instrument [Line Items]
Payments for convertible note hedges				$ 143,200
Loss on debt extinguishment					$ 64,900
Number of securities called by warrants or rights (in shares) \| shares				11.8
Exercise price of warrants (in dollars per share) \| $ / shares				$ 73.46	$ 73.46
Proceeds from issuance of warrants				$ 88,000
Transaction cost				55,200
Share price threshold for dilutive effect of convertible debt (in dollars per share) \| $ / shares					$ 10
Dilutive effect of $10 increase in share price (in shares) \| shares					0.4
Dilutive effect of warrants (in shares) \| shares					2.1
Share price threshold for dilutive effect of warrants (in dollars per share) \| $ / shares					$ 83.46
Principal amount				$ 1,000
2027 Convertible Senior Notes
Debt Instrument [Line Items]
Interest rate, stated percentage					0.25%
Principal amount			$ 1,000
Convertible Debt \| 2023 Convertible Senior Notes
Debt Instrument [Line Items]
Interest rate, stated percentage				0.00%	0.00%
Face amount				$ 575,000
Convertible debt			416,500	$ 75,000
Conversion ratio				20.4705
Conversion price (in dollars per share) \| $ / shares				$ 48.85
Payments for convertible note hedges				$ 143,175
Threshold trading days				20	20
Threshold consecutive trading days \| d				30	30
Threshold percentage of stock price trigger				130.00%	130.00%
Proceeds from Hedge, Financing Activities			39,900
Payments for unwinding of warrants			18,400
Debt outstanding								$ 145,700
Debt repurchase amount			12,800
Redemption price, percentage				100.00%
Proceeds From Unwind Transactions			$ 21,500
Unamortized discount, net				$ 10,781
Less: other issuance costs				(707)
Transaction costs attributable to equity component						3,000
Debt instrument, term					5 months
Proceeds from issuance of warrants				87,975
Principal amount				$ 575,000	$ 145,704	575,000
Convertible Debt \| 2023 Convertible Senior Notes \| Exchange Transactions
Debt Instrument [Line Items]
Face amount								416,500
Convertible Debt \| 2023 Convertible Senior Notes \| Cash Transaction
Debt Instrument [Line Items]
Debt repurchase amount								12,800
Convertible Debt \| 2026 Convertible Senior Notes
Debt Instrument [Line Items]
Interest rate, stated percentage		2.50%			2.50%
Face amount	$ 750,000
Conversion ratio		0.036036
Conversion price (in dollars per share) \| $ / shares		$ 27.75	$ 27.75
Threshold trading days \| d		20
Threshold consecutive trading days \| d		30
Threshold percentage of stock price trigger		150.00%
Redemption price, percentage		100.00%
Debt instrument, term					4 years 1 month 6 days
Proceeds from the issuance of convertible notes, net of issuance costs	723,720
Payments of debt issuance costs	$ 26,300
Debt instrument, principal amount for conversion into common stock		$ 1,000
Principal amount					$ 750,000	$ 750,000
Derivative liability		$ 230,900	$ 698,200
Convertible Debt \| 2027 Convertible Senior Notes
Debt Instrument [Line Items]
Interest rate, stated percentage			0.25%		0.25%
Face amount			$ 575,000
Convertible debt			$ 477,300
Conversion ratio			17.3192
Conversion price (in dollars per share) \| $ / shares			$ 57.74
Threshold trading days \| PurchasePeriod			20
Threshold consecutive trading days \| PurchasePeriod			30
Debt Instrument Issued For Cash Net Of Expense			$ 88,400
Debt repurchase amount			$ 14,700
Redemption price, percentage			100.00%
Debt Instrument Issued For Cash			$ 97,700
Debt instrument, term					5 years 2 months 12 days
Debt instrument, principal amount for conversion into common stock			$ 1,000
Principal amount					$ 575,000
Convertible Debt \| 2027 Convertible Senior Notes \| Exchange Transactions
Debt Instrument [Line Items]
Face amount								$ 477,300
Minimum \| Convertible Debt \| 2027 Convertible Senior Notes
Debt Instrument [Line Items]
Threshold percentage of stock price trigger			130.00%
Common Class A \| Convertible Debt \| 2023 Convertible Senior Notes
Debt Instrument [Line Items]
Threshold percentage of stock price trigger				98.00%
Share price (in dollars per share) \| $ / shares					$ 15.13
Fair value of common stock (in dollars per share) \| $ / shares					$ 15.13
Principal amount				$ 1,000
Common Class A \| Convertible Debt \| 2027 Convertible Senior Notes
Debt Instrument [Line Items]
Debt repurchase amount			$ 58,500
Stock Repurchase Program, Number of Shares Authorized to be Repurchased \| shares			1.4
Common Class A \| Maximum \| Convertible Debt \| 2027 Convertible Senior Notes
Debt Instrument [Line Items]
Threshold percentage of stock price trigger			98.00%

Convertible Senior Notes - Net Proceeds from Notes (Details) - 2023 Convertible Senior Notes - USD ($) $ in Thousands	1 Months Ended
	Jan. 31, 2018	Jul. 31, 2022	Jul. 31, 2021
Debt Instrument [Line Items]
Principal amount	$ 1,000
Less: cost of the bond hedges	(143,200)
Add: proceeds from the sale of warrants	88,000
Convertible Debt
Debt Instrument [Line Items]
Principal amount	575,000	$ 145,704	$ 575,000
Less: initial purchasers' discount	(10,781)
Less: cost of the bond hedges	(143,175)
Add: proceeds from the sale of warrants	87,975
Less: other issuance costs	(707)
Net proceeds	$ 508,312

Convertible Senior Notes - Components of Debt (Details) - USD ($)
$ in Thousands

Jul. 31, 2022

Sep. 30, 2021

Jul. 31, 2021

Jan. 31, 2018

2023 Convertible Senior Notes

Debt Instrument [Line Items]

Principal amount

$ 1,000

2027 Convertible Senior Notes

Debt Instrument [Line Items]

Principal amount

$ 1,000

Convertible Debt | 2023 Convertible Senior Notes

Debt Instrument [Line Items]

Principal amount

$ 145,704

$ 575,000

Unamortized debt discount

^[1]

(48,616)

Unamortized debt issuance costs

^[1]

(248)

(2,713)

Net carrying amount

145,456

523,671

Carrying amount of equity component

^[2]

148,598

Convertible Debt | 2026 Convertible Senior Notes

Debt Instrument [Line Items]

Principal amount

750,000

Non-cash interest expense converted to principal

27,997

8,906

Unamortized debt discount

^[3]

(169,438)

(203,619)

Unamortized debt issuance costs

^[3]

(19,359)

(23,264)

Net carrying amount

589,200

$ 532,023

Convertible Debt | 2027 Convertible Senior Notes

Debt Instrument [Line Items]

Principal amount

575,000

Unamortized debt issuance costs

^[4]

(7,995)

Net carrying amount

$ 567,005

[1]	Included in our consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2023 Notes using the effective interest rate method. As of July 31, 2021, the effective interest rate was 6.62%. As of July 31, 2022, the effective interest rate was 0.41%.
[2]	Included in our consolidated balance sheets as of July 31, 2021 within additional paid-in capital, net of $3.0 million in equity issuance costs.
[3]	Included in our consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2026 Notes using the effective interest rate method. The effective interest rate is 7.05%
[4]	Included in our consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2027 Notes using the effective interest rate method. The effective interest rate is 0.52%.

Convertible Senior Notes - Components of Notes (Parenthetical) (Details) - Convertible Debt - USD ($) $ in Millions	Jul. 31, 2022	Jul. 31, 2021
2023 Convertible Senior Notes
Debt Instrument [Line Items]
Effective interest rate	0.41%	6.62%
Payments of offering costs		$ (3.0)
2026 Convertible Senior Notes
Debt Instrument [Line Items]
Effective interest rate	7.05%
2027 Convertible Senior Notes
Debt Instrument [Line Items]
Effective interest rate	0.52%

Convertible Senior Notes - Interest Expense Recognized (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2020
Debt Instrument [Line Items]
Non-cash interest expense	$ 19,270	$ 16,074
Convertible Debt \| 2023 Convertible Senior Notes
Debt Instrument [Line Items]
Interest expense related to amortization of debt discount	0	31,682	$ 29,658
Interest expense related to amortization of debt issuance costs	844	1,767	1,654
Total interest expense	844	33,449	$ 31,312
Convertible Debt \| 2026 Convertible Senior Notes
Debt Instrument [Line Items]
Interest expense related to amortization of debt discount	34,180	27,291
Interest expense related to amortization of debt issuance costs	3,906	3,119
Non-cash interest expense	19,270	16,074
Total interest expense	57,356	$ 46,484
Convertible Debt \| 2027 Convertible Senior Notes
Debt Instrument [Line Items]
Contractual Interest Expense	1,229
Interest expense related to amortization of debt issuance costs	1,302
Total interest expense	$ 2,531

Leases - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2020
Lessee, Lease, Description [Line Items]
Operating lease, cost	$ 43,300	$ 42,600	$ 39,100
Finance lease, cost	2,400	700
Impairment loss	597	1,420	3,002
Right-of-use asset, impairment loss		500	1,800
Impairment of leasehold		$ 900	$ 1,200
Operating lease early exit expenses	600
Lease not yet commenced, undiscounted amount	$ 7,300
Minimum
Lessee, Lease, Description [Line Items]
Remaining lease term	1 year
Lease not yet commenced, term of contract	3 years
Maximum
Lessee, Lease, Description [Line Items]
Remaining lease term	8 years
Lease not yet commenced, term of contract	8 years

Leases - Supplemental Balance Sheet (Details) - USD ($)
$ in Thousands

Jul. 31, 2022

Jul. 31, 2021

Operating Lease, Liability [Abstract]

Operating lease right-of-use assets, gross

$ 188,060

$ 170,277

Accumulated amortization

(69,320)

(64,374)

Operating lease right-of-use assets, net

118,740

105,903

Operating lease liabilities—current

39,801

42,670

Operating lease liabilities—non-current

89,782

86,599

Total operating lease liabilities

$ 129,583

$ 129,269

Weighted average remaining lease term (in years)

5 years 1 month 6 days

3 years 1 month 6 days

Weighted average discount rate:

5.70%

5.50%

Finance Lease, Liability [Abstract]

Finance lease right-of-use assets, gross

^[1]

$ 13,501

$ 8,972

Accumulated amortization

^[1]

(3,053)

(687)

Finance Lease, Right-of-Use Asset, after Accumulated Amortization, Total

^[1]

10,448

8,285

Finance lease liabilities-current

^[2]

2,685

1,772

Finance lease liabilities-non-current

^[3]

7,806

6,527

Finance Lease, Liability, Total

$ 10,491

$ 8,299

Weighted average remaining lease term (in years)

3 years 10 months 24 days

4 years 8 months 12 days

Weighted average discount rate

5.90%

6.70%

Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]

Liabilities

Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]

Assets, Current

Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]

Liabilities, Current

Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]

Other Liabilities, Noncurrent

[1]	Included in our consolidated balance sheets within property and equipment, net.
[2]	Included in our consolidated balance sheets within accrued expenses and other current liabilities.
[3]	Included in our consolidated balance sheets within other liabilities—non-current.

Leases - Supplemental Cash Flow and Other Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2022	Jul. 31, 2021
Leases [Abstract]
Operating cash flows from operating leases	$ 48,509	$ 46,216
Financing cash flows from finance leases	1,089	459
Lease liabilities arising from obtaining right-of-use assets from operating leases	55,797	16,174
Lease liabilities arising from obtaining right-of-use assets from finance leases	$ 4,529	$ 9,622

Leases - Remaining Maturity Under Topic 842 (Details) - USD ($)
$ in Thousands

Jul. 31, 2022

Jul. 31, 2021

$ 43,199

30,393

17,100

13,805

12,699

36,396

153,592

Less: imputed interest

(24,009)

Total operating lease liabilities

129,583

$ 129,269

Less: current lease obligations

(39,801)

(42,670)

Long-term lease obligations

89,782

86,599

Finance leases

2,750

2,750

2,750

2,048

337

Finance Lease, Liability, Payment, Due, Total

10,635

Less: imputed interest

(144)

Finance Lease, Liability, Total

10,491

8,299

Less: current lease obligations

^[1]

(2,685)

(1,772)

Finance lease liabilities-non-current

^[2]

(7,806)

$ (6,527)

Total

45,949

33,143

19,850

15,853

13,036

36,396

164,227

Less: imputed interest

(24,153)

Total lease obligation

140,074

Less: current lease obligations

(42,486)

Long-term lease obligations

$ 97,588

[1]	Included in our consolidated balance sheets within accrued expenses and other current liabilities.
[2]	Included in our consolidated balance sheets within other liabilities—non-current.

Commitments and Contingencies - Additional Information (Details) $ in Millions	Jul. 31, 2022 USD ($)
Non-contract Vendors
Loss Contingencies [Line Items]
Purchase obligation	$ 88.7
Contract Manufacturer
Loss Contingencies [Line Items]
Purchase obligation	$ 82.3

Stockholders' Equity - Additional Information (Details)	1 Months Ended	12 Months Ended
Stockholders' Equity - Additional Information (Details)	Sep. 30, 2021 USD ($) $ / shares shares	Jul. 31, 2022 USD ($) Class Vote $ / shares shares	Jul. 31, 2021 USD ($) $ / shares shares	Jan. 03, 2022 $ / shares	Aug. 31, 2020 USD ($)
Class of Stock [Line Items]
Common stock, shares authorized (in shares)		1,042,004,000	1,200,000,000
Common stock, shares issued (in shares)		226,938,000	214,210,000
Number of Authorized Common Stock \| Class		1
Common stock, shares outstanding (in shares)		226,938,000	214,210,000
Payments for repurchase of common stock \| $		$ 58,570,000	$ 125,079,000
Stock repurchase program, remaining authorization amount \| $			$ 0
Common Class A [Member]
Class of Stock [Line Items]
Common stock, shares authorized (in shares)		1,000,000,000	1,000,000,000
Common stock, par value (in dollars per share) \| $ / shares		$ 0.000025	$ 0.000025	$ 0.000025
Common stock, shares issued (in shares)		226,938,000	208,579,000
Common stock, shares outstanding (in shares)		226,938,000	208,579,000
Proceeds from Issuance of Common Stock \| $	$ 58,500,000
Common stock number of votes per share \| Vote		1
Stock repurchase program, authorized amount \| $					$ 125,000,000.0
Repurchase and retirement of common stock (in shares)	1,400,000		5,200,000
Stock repurchase price (in dollars per share) \| $ / shares	$ 42.77		$ 24.15
Payments for repurchase of common stock \| $	$ 97,700,000		$ 125,000,000.0
Common Class B [Member]
Class of Stock [Line Items]
Common stock, shares authorized (in shares)		42,004,000	200,000,000
Common stock, par value (in dollars per share) \| $ / shares		$ 0.000025	$ 0.000025	$ 0.000025
Common stock, shares issued (in shares)		0	5,631,000
Common stock, shares outstanding (in shares)		0	5,631,000

Stockholders' Equity - Schedule of Reserved Shares of Common Stock for Future Issuance (Details) - shares shares in Thousands	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2020
Class of Stock [Line Items]
Share reserved for future equity grants (in shares)	15,200
Shares underlying outstanding stock options (in shares)	1,689	3,334	7,546
Shares reserved for future issuance (in shares)	41,346
RSUs
Class of Stock [Line Items]
Shares underlying outstanding restricted stock units (in shares)	22,136	21,708	22,632
Employee Stock Purchase Plan
Class of Stock [Line Items]
Shares reserved for future issuance (in shares)	2,362
Common Class A \| 2016 Plan
Class of Stock [Line Items]
Share reserved for future equity grants (in shares)	15,159
Shares reserved for future issuance (in shares)	22,400

Equity Incentive Plans - Additional Information (Details)					1 Months Ended		12 Months Ended
	Aug. 01, 2022 shares	Aug. 02, 2021 shares	Aug. 01, 2020 shares	Dec. 13, 2019 USD ($) PurchasePeriod shares	Oct. 31, 2021 $ / shares shares	Dec. 31, 2020 $ / shares shares	Jul. 31, 2022 USD ($) Plan $ / shares shares	Jul. 31, 2021 USD ($) $ / shares shares	Jul. 31, 2020 USD ($) shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of equity incentive plans \| Plan							3
Shares reserved for future issuance (in shares)							41,346,000
Number of shares available for grant (in shares)							15,200,000
Options granted (in shares)							0	0	0
Exercises in period, intrinsic value \| $							$ 35,000,000.0	$ 90,500,000	$ 23,400,000
Proceeds from stock options exercised \| $							6,500,000	15,100,000	6,900,000
Options vested in period, fair value \| $								200,000	1,000,000.0
Monetary cap \| $				$ 25,000
Share cap (in shares)				1,000
Offering period duration (in months)				12 months
Number of six-month purchase periods \| PurchasePeriod				2
Proceeds from Stock Plans \| $							67,826,000	$ 65,766,000	57,797,000
Compensation not yet recognized \| $							$ 583,400,000
Period for recognition (in years)							2 years 6 months
Market Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments outstanding (in shares)							1,100,000
Employee stock purchase plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance (in shares)							2,362,000
Percent of eligible compensation (up to)				15.00%
Purchase price of common stock, percent				85.00%
ESPP stock issued during period (in shares)							2,800,000
Employee stock purchase plan \| 2016 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Proceeds from Stock Plans \| $							$ 62,600,000
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)							4 years
Expiration period (in years)							10 years
Incentive Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price, percent of estimated fair value							100.00%
Non-qualified Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price, percent of estimated fair value							100.00%
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)							15,575,000	13,732,000
Granted (in dollars per share) \| $ / shares							$ 30.92	$ 29.60
Released (in dollars per share) \| $ / shares							$ 32.68	$ 32.58
RSUs \| Market Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)					400,000	703,117
Granted (in dollars per share) \| $ / shares					$ 46.20	$ 35.69
Vesting percentage					200.00%	133.00%
Award vesting period (in years)					2 years 9 months 18 days	4 years
Options vested in period, fair value \| $							$ 314,600,000	$ 317,400,000	$ 298,200,000
RSUs \| Market Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)						75,000
Granted (in dollars per share) \| $ / shares						$ 27.54
Award vesting period (in years)						3 years 10 months 24 days
Employee Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance (in shares)							39,000,000.0
Common Class A \| 2016 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance (in shares)							22,400,000
Annual increase (in shares)							18,000,000.0
Annual increase, percent of outstanding shares							5.00%
Number of additional shares authorized (in shares)	11,300,000	10,700,000	10,100,000
Number of shares available for grant (in shares)							15,159,000
Common Class A \| Employee Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance (in shares)				11,500,000
Number of additional shares authorized (in shares)				9,200,000
Principal Owner \| Incentive Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period (in years)							5 years
Exercise price, percent of estimated fair value							110.00%

Equity Incentive Plans - RSU (Details) - RSUs - $ / shares shares in Thousands	12 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2020
Number of Shares
Outstanding, beginning balance (in shares)	21,708	22,632
Granted (in shares)	15,575	13,732
Released (in shares)	(9,626)	(9,744)
Canceled/forfeited (in shares)	(5,521)	(4,912)
Outstanding, ending balance (in shares)	22,136	21,708
Grant Date Fair Value per Share
Outstanding (in dollars per share)	$ 29.81	$ 30.98	$ 32.70
Granted (in dollars per share)	30.92	29.60
Released (in dollars per share)	32.68	32.58
Canceled/forfeited (in dollars per share)	$ 32.55	$ 31.87

Equity Incentive Plans - Stock Options (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2020
Number of Shares
Beginning balance (in shares)	3,334,000	7,546,000
Options granted (in shares)	0	0	0
Options exercised (in shares)	(1,643,000)	(3,712,000)
Options canceled/forfeited (in shares)	(2,000)	(500,000)
Ending balance (in shares)	1,689,000	3,334,000	7,546,000
Exercisable (in shares)	1,689,000	3,334,000
Weighted Average Exercise Price
Beginning balance (in dollars per share)	$ 5.20	$ 5.10
Options granted (in dollars per share)	0	0
Options exercised (in dollars per share)	3.94	4.07
Options canceled/forfeited (in dollars per share)	13.04	12.00
Ending balance (in dollars per share)	6.43	5.20	$ 5.10
Exercisable (in dollars per share)	$ 6.43	$ 5.20
Additional Disclosures
Outstanding (in years)	1 year 10 months 24 days	2 years 9 months 18 days	3 years 7 months 6 days
Exercisable (in years)	1 year 10 months 24 days	2 years 9 months 18 days
Outstanding, intrinsic value	$ 14,707	$ 102,740	$ 129,010
Exercisable, intrinsic value	$ 14,707	$ 102,739

Equity Incentive Plans - ESPP (Details) - Employee stock purchase plan	12 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	9 months 21 days	9 months 7 days	11 months 1 day
Risk-free interest rate	1.00%	0.10%	0.10%
Volatility	43.30%	56.90%	73.40%
Dividend yield	0.00%	0.00%	0.00%

Equity Incentive Plans - Stock Based Compensation Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2020
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	$ 343,246	$ 358,545	$ 351,998
Cost of revenue \| Product
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	7,379	6,023	5,334
Cost of revenue \| Support, Entitlements and Other Services
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	30,846	24,460	22,014
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	104,592	122,815	126,015
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	143,759	150,856	153,252
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	$ 56,670	$ 54,391	$ 45,383

Restructuring Charges (Additional Information) (Details) $ in Millions	1 Months Ended	12 Months Ended
	Aug. 31, 2022 USD ($) Employee	Jul. 31, 2022 USD ($)
Restructuring Cost and Reserve [Line Items]
Restructuring description	In August 2022, we announced a plan to reduce our global headcount by approximately 270 employees, which represents approximately 4% of our total employees,
Restructuring Charges		$ 11.2
Accrued compensation and benefits		11.2
Employee
Restructuring Cost and Reserve [Line Items]
Number of employees reduced our global headcount \| Employee	270
Number of employees reduced our global headcount, Percent	4.00%
Sales and marketing expense
Restructuring Cost and Reserve [Line Items]
Restructuring Charges		10.3
Research And Development Expense
Restructuring Cost and Reserve [Line Items]
Restructuring Charges		0.6
Support entitlements and other services cost of revenue
Restructuring Cost and Reserve [Line Items]
Restructuring Charges		0.2
General and administrative expense
Restructuring Cost and Reserve [Line Items]
Restructuring Charges		$ 0.1
Minimum \| One-time severance
Restructuring Cost and Reserve [Line Items]
Estimated recognize pre tax restructuring charges	$ 20.0
Maximum \| Other termination benefit costs
Restructuring Cost and Reserve [Line Items]
Estimated recognize pre tax restructuring charges	$ 25.0

Net Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2020
Earnings Per Share [Abstract]
Net loss	$ (797,538)	$ (1,034,260)	$ (872,883)
Weighted average shares basic and diluted	220,529	206,475	194,719
Net loss per share attributable to common stockholders basic and diluted	$ (3.62)	$ (5.01)	$ (4.48)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

Net Loss Per Share - Antidilutive Securities (Details) - shares shares in Thousands	12 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	66,304	29,662	35,052
Outstanding stock options and RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	23,825	25,042	30,178
Employee stock purchase plan
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	2,511	2,838	4,368
Common stock issuable upon the conversion of convertible debt
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	39,968	1,529	0
Contingently issuable shares pursuant to acquisitions
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	0	253	506

Net Loss Per Share - Antidilutive Securities (Additional Information) (Details) - $ / shares	12 Months Ended
	Jul. 31, 2022	Jan. 03, 2022	Jul. 31, 2021
Accounting Standards Update 2020-06 [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Indirect Effects	We adopted ASU 2020-06 on August 1, 2021 using the modified retrospective method, applicable to our convertible senior notes outstanding as of adoption. We have not changed any previously disclosed amounts or provided additional disclosures for comparative periods. ASU 2020-06 requires the if-converted method to be applied for all convertible instruments when calculating diluted earnings per share.
Common Class A [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common Stock, Par or Stated Value Per Share	$ 0.000025	$ 0.000025	$ 0.000025
Common Class B [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common Stock, Par or Stated Value Per Share	$ 0.000025	$ 0.000025	$ 0.000025

Income Taxes - Schedule of Income Before Provision for Income Taxes, Domestic and Foreign (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2020
Income Tax Disclosure [Abstract]
Domestic	$ (833,507)	$ (1,066,307)	$ (905,840)
Foreign	55,233	50,534	50,619
Loss before provision for income taxes	$ (778,274)	$ (1,015,773)	$ (855,221)

- Definition

Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 940
-SubTopic 20
-Section 25
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(10))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(8))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(15))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

+ Details

Income Taxes - Schedule of Provision for Income Taxes, Current and Deferred (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2020
Current:
U.S. federal	$ 13	$ 9	$ 175
State and local	77	99	79
Foreign	21,578	21,801	18,033
Total current taxes	21,668	21,909	18,287
Deferred:
U.S. federal	23	24	80
State and local	0	0	0
Foreign	(2,427)	(3,446)	(705)
Total deferred taxes	(2,404)	(3,422)	(625)
Total	$ 19,264	$ 18,487	$ 17,662

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2022	Jul. 31, 2021
Operating Loss Carryforwards [Line Items]
Federal statutory income tax rate	21.00%
Valuation allowance for deferred tax assets	$ 1,002,546	$ 918,689
Valuation allowance increase	83,900	$ 206,600
Unrecognized tax benefits that would impact effective tax rate	14,400
Cash and cash equivalents in foreign subsidiaries	165,900
Accounts payable and accrued liabilities	5,300
United States of America, Dollars
Operating Loss Carryforwards [Line Items]
Valuation allowance for deferred tax assets	1,000,000
Cash and cash equivalents in foreign subsidiaries	73,100
Federal
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	3,000,000
Federal \| Research Credit Carryforwards
Operating Loss Carryforwards [Line Items]
Research credit carryforwards	124,000
State
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	1,800,000
State \| Research Credit Carryforwards
Operating Loss Carryforwards [Line Items]
Research credit carryforwards	96,400
Foreign Tax Authority \| Research Credit Carryforwards
Operating Loss Carryforwards [Line Items]
Research credit carryforwards	$ 12,100

Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2020
Income Tax Disclosure [Abstract]
U.S. federal income tax at statutory rate	$ (163,438)	$ (213,391)	$ (179,514)
Change in valuation allowance	117,292	171,270	164,453
Non-deductible item on fair value remeasurement derivative liability	41,589	56,546	0
Stock-based compensation	14,462	4,663	30,913
Effect of foreign operations	11,210	9,851	12,676
Research and development tax credits	(9,455)	(14,694)	(19,210)
Non-deductible expenses	6,646	1,739	5,393
Change in unrecognized tax benefit	655	2,631	1,863
State income taxes	77	99	79
Transfer pricing adjustments	0	0	7
Other	226	(227)	1,002
Total	$ 19,264	$ 18,487	$ 17,662

Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jul. 31, 2021
Deferred tax assets:
Net operating loss carryforward	$ 665,757	$ 573,944
Tax credit carryforward	184,376	164,984
Deferred revenue	170,243	168,417
Leases	38,843	40,011
Interest expense carryforward	32,692	15,492
Intangible assets	25,403	28,557
Accruals and reserves	23,045	21,727
Stock-based compensation	17,631	18,957
Property and equipment	4,115	3,385
Other assets	23,412	26,394
Total deferred tax assets	1,185,517	1,061,868
Deferred tax liabilities:
Deferred commission expense	(86,253)	(83,054)
Leases	(39,886)	(38,368)
Convertible notes	(38,925)	(246)
Prepaid expenses	(2,290)	(2,013)
Property and equipment	(1,271)	(3,681)
Acquisition-related	(1,224)	(4,633)
Other	(3,142)	(2,764)
Total deferred tax liabilities	(172,991)	(134,759)
Valuation allowance	(1,002,546)	(918,689)
Net deferred tax assets	$ 9,980	$ 8,420

Income Taxes - Schedule of Unrecognized Tax Benefits (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2022	Jul. 31, 2021
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance, beginning balance	$ 89,775	$ 85,257
Increases related to current year tax positions	3,499	4,335
Increases related to prior year tax positions	604	328
Decreases related to prior year tax positions	(2,263)	0
Lapse of statute of limitations/Settlements	(942)	(145)
Balance, ending balance	$ 90,673	$ 89,775

Segment Information - Schedule of Revenue by Geographic Area (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2020
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	$ 1,580,796	$ 1,394,364	$ 1,307,682
U.S.
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	887,141	758,128	706,110
Europe, the Middle East and Africa
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	374,186	320,837	277,489
Asia Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	274,373	260,637	265,092
Other Americas
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	$ 45,096	$ 54,762	$ 58,991

- Definition

+ References

+ Details

Segment Information - Schedule of Sets Forth Long-Lived Assets Include Property and Equipment, Net (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jul. 31, 2021
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-Lived Assets	$ 113,440	$ 131,621
UNITED STATES
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-Lived Assets	74,472	86,468
Non-US [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-Lived Assets	$ 38,968	$ 45,153

Subsequent Events - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2022	Sep. 30, 2021	Sep. 22, 2021
Subsequent Event [Line Items]
Loss on debt extinguishment	$ (64,910)
A 2027 Convertible Senior Notes [Member] \| Convertible Debt [Member]
Subsequent Event [Line Items]
Face amount		$ 575,000
Debt repurchase amount		14,700
A 2027 Convertible Senior Notes [Member] \| Convertible Debt [Member] \| Exchange Transactions
Subsequent Event [Line Items]
Face amount			$ 477,300
Common Class A \| A 2027 Convertible Senior Notes [Member] \| Convertible Debt [Member]
Subsequent Event [Line Items]
Debt repurchase amount		$ 58,500